<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92376</article-id><article-id pub-id-type="doi">10.7554/eLife.92376</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Activity-dependent mitochondrial ROS signaling regulates recruitment of glutamate receptors to synapses</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-334120"><name><surname>Doser</surname><given-names>Rachel L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9057-4371</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-337859"><name><surname>Knight</surname><given-names>Kaz M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3184-3620</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-337860"><name><surname>Deihl</surname><given-names>Ennis W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0003-6737-8964</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-333914"><name><surname>Hoerndli</surname><given-names>Frederic J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6838-0386</contrib-id><email>frederic.hoerndli@colostate.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03k1gpj17</institution-id><institution>Department of Biomedical Science, Colorado State University</institution></institution-wrap><addr-line><named-content content-type="city">Fort Collins</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03k1gpj17</institution-id><institution>Department of Health and Exercise Sciences, Colorado State University</institution></institution-wrap><addr-line><named-content content-type="city">Fort Collins</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03k1gpj17</institution-id><institution>Cellular and Molecular Biology Graduate Program, Colorado State University</institution></institution-wrap><addr-line><named-content content-type="city">Fort Collins</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dickman</surname><given-names>Dion K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>University of Southern California</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Chen</surname><given-names>Lu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>14</day><month>03</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e92376</elocation-id><history><date date-type="received" iso-8601-date="2023-08-31"><day>31</day><month>08</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-03-13"><day>13</day><month>03</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2023-08-07"><day>07</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.07.552290"/></event></pub-history><permissions><copyright-statement>© 2024, Doser et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Doser et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92376-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92376-figures-v2.pdf"/><abstract><p>Our understanding of mitochondrial signaling in the nervous system has been limited by the technical challenge of analyzing mitochondrial function in vivo. In the transparent genetic model <italic>Caenorhabditis elegans,</italic> we were able to manipulate and measure mitochondrial reactive oxygen species (mitoROS) signaling of individual mitochondria as well as neuronal activity of single neurons in vivo. Using this approach, we provide evidence supporting a novel role for mitoROS signaling in dendrites of excitatory glutamatergic <italic>C. elegans</italic> interneurons. Specifically, we show that following neuronal activity, dendritic mitochondria take up calcium (Ca<sup>2+</sup>) via the mitochondrial Ca<sup>2+</sup> uniporter (MCU-1) that results in an upregulation of mitoROS production. We also observed that mitochondria are positioned in close proximity to synaptic clusters of GLR-1, the <italic>C. elegans</italic> ortholog of the AMPA subtype of glutamate receptors that mediate neuronal excitation. We show that synaptic recruitment of GLR-1 is upregulated when MCU-1 function is pharmacologically or genetically impaired but is downregulated by mitoROS signaling. Thus, signaling from postsynaptic mitochondria may regulate excitatory synapse function to maintain neuronal homeostasis by preventing excitotoxicity and energy depletion.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>glutamate</kwd><kwd>synapse</kwd><kwd>transport</kwd><kwd>mitochondria</kwd><kwd>confocal microscopy</kwd><kwd>reactive oxygen species</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS115947</award-id><principal-award-recipient><name><surname>Hoerndli</surname><given-names>Frederic J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100007235</institution-id><institution>CVMBS, Colorado State</institution></institution-wrap></funding-source><award-id>College Research Council grant</award-id><principal-award-recipient><name><surname>Doser</surname><given-names>Rachel L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>In response to neuronal activity in vivo, mitochondria in dendrites of excitatory neurons inhibit recruitment of ionotropic glutamate receptors through a reactive oxygen signaling mechanism.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>As the predominant excitatory synapse type in the brain, glutamatergic synapses are important for organismal physiology and homeostasis as well as much of the brain’s processing. Plasticity, or the change in efficacy, of these synapses underlies learning and memory formation. Although presynaptic changes contribute to synaptic transmission strength, the number of ionotropic glutamate receptors, especially the α-amino-3-hydroxy-5-methyl-4-isoxazole (AMPA) subtype (AMPARs), at the postsynaptic membrane is a strong correlate of synaptic strength. Changes in synaptic expression of AMPARs is a calcium (Ca<sup>2+</sup>)-dependent, multi-step process involving long-distance transport of the receptors by molecular motors (<xref ref-type="bibr" rid="bib59">Kim and Lisman, 2001</xref>; <xref ref-type="bibr" rid="bib95">Setou et al., 2002</xref>; <xref ref-type="bibr" rid="bib53">Hoerndli et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Esteves da Silva et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Hangen et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Hoerndli et al., 2022</xref>), delivery of AMPAR-containing vesicles to synaptic sites (<xref ref-type="bibr" rid="bib113">Yang et al., 2008</xref>; <xref ref-type="bibr" rid="bib54">Hoerndli et al., 2015</xref>), exocytosis and endocytosis of AMPARs to the membrane (<xref ref-type="bibr" rid="bib32">Ehlers, 2000</xref>; <xref ref-type="bibr" rid="bib114">Yudowski et al., 2007</xref>), as well as reorganization of postsynaptic proteins and cytoskeletal architecture (<xref ref-type="bibr" rid="bib20">Choquet and Triller, 2013</xref>; <xref ref-type="bibr" rid="bib76">Nakahata and Yasuda, 2018</xref>; <xref ref-type="bibr" rid="bib47">Gutiérrez et al., 2021</xref>).</p><p>The mechanisms underlying postsynaptic plasticity are metabolically demanding processes requiring the upregulation of mitochondrial metabolism to meet energy demands (<xref ref-type="bibr" rid="bib107">Wacquier et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Faria-Pereira and Morais, 2022</xref>). There is growing evidence that mitochondria are also important for other cellular functions, including regulation of gene expression, Ca<sup>2+</sup> homeostasis, inflammatory signaling, and lipid biogenesis (<xref ref-type="bibr" rid="bib19">Chae et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Hirabayashi et al., 2017</xref>). Interestingly, the generation of reactive oxygen species (ROS), such as superoxide and hydrogen peroxide, by the mitochondrial respiratory chain and other matrix proteins (<xref ref-type="bibr" rid="bib4">Angelova and Abramov, 2018</xref>) is gaining traction as an essential signaling mechanism with many identified downstream effectors in neurons (<xref ref-type="bibr" rid="bib99">Sies and Jones, 2020</xref>; <xref ref-type="bibr" rid="bib51">Hidalgo and Arias-Cavieres, 2016</xref>). It has become clear that ROS act as a physiological signal (<xref ref-type="bibr" rid="bib99">Sies and Jones, 2020</xref>) that is necessary for neuronal development (<xref ref-type="bibr" rid="bib82">Oswald et al., 2018b</xref>), excitatory and inhibitory neurotransmission (<xref ref-type="bibr" rid="bib13">Biswas et al., 2022</xref>), as well as synaptic plasticity (<xref ref-type="bibr" rid="bib72">Massaad and Klann, 2011</xref>; <xref ref-type="bibr" rid="bib81">Oswald et al., 2018a</xref>).</p><p>For instance, evidence accumulated over the last 25 years has demonstrated that ROS signaling is required for normal synaptic expression of AMPARs. Early evidence came from results suggesting abnormal plasticity of glutamatergic synapses, learning and memory when ROS are elevated or diminished (<xref ref-type="bibr" rid="bib72">Massaad and Klann, 2011</xref>; <xref ref-type="bibr" rid="bib61">Klann et al., 1998</xref>; <xref ref-type="bibr" rid="bib63">Knapp and Klann, 2002</xref>; <xref ref-type="bibr" rid="bib56">Huddleston et al., 2008</xref>). Since these studies, we and others have shown that ROS signaling can regulate the number of synaptic AMPARs via ROS-dependent regulation of AMPAR phosphorylation (<xref ref-type="bibr" rid="bib66">Lee et al., 2012</xref>) or the long-distance transport and delivery of AMPARs to synapses (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Doser and Hoerndli, 2022</xref>). Despite our understanding of several downstream effectors of ROS signaling, it is unclear when or where ROS signaling originates in neurons in vivo. As previously mentioned, ROS is predominantly generated as a by-product of mitochondrial respiration but is also produced by NADPH oxidase and peroxisome enzymes (<xref ref-type="bibr" rid="bib99">Sies and Jones, 2020</xref>). Despite mitochondria being the major source of ROS, it has not been assessed in vivo if or how mitochondrial ROS (mitoROS) production is regulated by neuronal activity. In addition, mitochondria are positioned at pre- and postsynaptic sites (<xref ref-type="bibr" rid="bib39">Freeman et al., 2017</xref>) where they likely contribute to synaptic function. However, our understanding of the roles mitochondria play at synapses has been limited by our ability to study mitochondrial function in vivo under physiological conditions.</p><p>The transparent nematode <italic>Caenorhabditis elegans</italic> is a powerful genetic model that has been widely accepted for studying mitochondrial function, Ca<sup>2+</sup> handling, and ROS signaling in vivo, especially in the context of aging and neurodegeneration (<xref ref-type="bibr" rid="bib7">Back et al., 2012</xref>; <xref ref-type="bibr" rid="bib84">Petriv and Rachubinski, 2004</xref>; <xref ref-type="bibr" rid="bib75">Morsci et al., 2016</xref>; <xref ref-type="bibr" rid="bib112">Xu and Chisholm, 2014</xref>; <xref ref-type="bibr" rid="bib2">Alvarez et al., 2020</xref>). Additionally, <italic>C. elegans</italic> has been used extensively in neuroscience research (<xref ref-type="bibr" rid="bib94">Sengupta and Samuel, 2009</xref>) due to their relatively simple nervous system composed of neurons whose gene expression and synaptic connections are completely mapped (<xref ref-type="bibr" rid="bib22">Cook et al., 2019</xref>; <xref ref-type="bibr" rid="bib105">Taylor et al., 2021</xref>). Importantly, most of the key players at glutamatergic synapses are conserved, including subunits of AMPARs and other glutamate receptor subtypes (<xref ref-type="bibr" rid="bib69">Maricq et al., 1995</xref>), and are regulated in a similar fashion to their vertebrate orthologs (<xref ref-type="bibr" rid="bib49">Hangen et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Hoerndli et al., 2015</xref>; <xref ref-type="bibr" rid="bib89">Rongo and Kaplan, 1999</xref>; <xref ref-type="bibr" rid="bib109">Widagdo et al., 2017</xref>). Using <italic>C. elegans</italic> to study the regulation of glutamatergic synapses<italic>,</italic> we have shown that Ca<sup>2+</sup> signaling regulates transport and delivery of GLR-1, the <italic>C. elegans</italic> ortholog of the AMPAR subunit GluA1, to synapses. Moreover, our previous work revealed that ROS signaling interacts with Ca<sup>2+</sup> signaling in the cell body and dendrites to control the amount of GLR-1 transport and regulate synaptic delivery of GLR-1 (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>). Thus, an interplay between ROS and Ca<sup>2+</sup> signaling at postsynaptic sites appears to be important for AMPAR localization to synapses, but the role of postsynaptic mitochondria in this process has not been addressed.</p><p>Here, using in vivo imaging and optogenetic tools in <italic>C. elegans,</italic> we assessed the role of postsynaptic mitochondria as signaling hubs that integrate neuronal activity and regulate AMPAR localization to synapses. We found that in response to neuronal activation, mitochondria take up Ca<sup>2+</sup>, resulting in an increase in their ROS production. Most dendritic mitochondria were located in close proximity to clusters of surface-localized GLR-1, which are representative of postsynaptic sites. To demonstrate the functional relevance of activity-dependent mitoROS signaling, we show that activity-dependent mitoROS production, requiring the mitochondrial Ca<sup>2+</sup> uniporter MCU-1, regulates transport, delivery, and recruitment of GLR-1 to synapses. Since the number of glutamate receptors at a synapse controls the efficacy of excitatory transmission, activity-induced mitoROS production may constitute a critical inhibitory feedback mechanism that balances neuronal excitability with cellular energy capacity.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Activity-dependent mitochondrial Ca<sup>2+</sup> uptake regulates synaptic recruitment of GLR-1</title><p>As in vertebrates, the majority of neuronal activation in <italic>C. elegans</italic> are due to glutamatergic transmission. Activation occurs when glutamate is released from a presynaptic neuron that binds to and opens the cation pore of postsynaptic glutamate receptors, including AMPARs. Influx of cations into the postsynaptic neuron initiates opening of voltage-gated Ca<sup>2+</sup> channels that causes a rapid increase in cytoplasmic Ca<sup>2+</sup>. This Ca<sup>2+</sup> activates a multitude of signaling cascades before being rapidly taken up by the endoplasmic reticulum and mitochondria or extruded to extracellular space (<xref ref-type="bibr" rid="bib16">Brini et al., 2013</xref>). Mitochondria in various neuronal subtypes have discrete Ca<sup>2+</sup> handling capabilities (<xref ref-type="bibr" rid="bib70">Márkus et al., 2016</xref>), so we first characterized mitochondrial Ca<sup>2+</sup> uptake in vivo in the neurites of the AVA glutamatergic interneurons. To do this, we co-expressed the light-sensitive cation channel ChRimson (<xref ref-type="bibr" rid="bib62">Klapoetke et al., 2014</xref>) with the mitochondrial calcium indicator mitoGCaMP (<xref ref-type="bibr" rid="bib6">Ashrafi et al., 2020</xref>) targeted to the inner mitochondrial matrix (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>). This combination of tools allowed us to measure Ca<sup>2+</sup> uptake by individual mitochondria following repetitive optical activation. It is important to note that our photoactivation protocol involved optical stimulation using a 1 s light pulse every 30 s (33.3 mHz), a rate that is similar to the spontaneous activity of AVA neurons (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>). This assay revealed that there is diversity in Ca<sup>2+</sup> handling among dendritic mitochondria. Some mitochondria take up the most Ca<sup>2+</sup> upon the first optical activation (Mito 1; <xref ref-type="fig" rid="fig1">Figure 1B and C</xref>, <xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>), whereas others uptake more Ca<sup>2+</sup> following the second or third stimulation (Mito 2; <xref ref-type="fig" rid="fig1">Figure 1B and C</xref>, <xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Neuronal activity causes mitochondrial Ca<sup>2+</sup> uptake via MCU-1.</title><p>(<bold>A</bold>) Illustration depicting transgenic expression and subcellular location of ChRimson and mitoGCaMP in the AVA neurons. (<bold>B</bold>) Representative images of mitoGCaMP fluorescence in a single Z-plane before and after four optical activations (strain: FJH 644). Scale bar = 5 µm. (<bold>C</bold>) Normalized mitoGCaMP fluorescence for the regions of interest in (<bold>B</bold>) during repetitive optical activation (+Light, 5 µW at 33.3 mHz). (<bold>D</bold>) Representative normalized mitoGCaMP traces (30 s) following optical stimulation (+Light) of the AVA neurons in worms pretreated with Ru360 and in untreated controls (strain: FJH 644) or <italic>mcu-1(lf</italic>) (strain: FJH 647). (<bold>E</bold>) Quantification of the maximum ∆F/F<sub>min</sub> of mitoGCaMP events and (<bold>F</bold>) total mitoGCaMP activity during a 2.5 min recording of AVA neurons optically activated every 30 s (n ≥ 20 mitochondria from 5 to 8 animals per group). (<bold>G</bold>) Normalized mitoGCaMP fluorescence following optical stimulation (+Light) of the AVA neuron in untreated controls as well as Ru360-treated worms at 0 or 60 min post treatment. (<bold>H</bold>) Quantification of the average maximum ∆F/F<sub>min</sub> of mitoGCaMP and (<bold>I</bold>) normalized total mitoGCaMP activity during a 2.5 min recording of AVA neurons optically activated every 30 s (n ≥ 20 mitochondria from 4 to 5 animals per group). Data is represented as mean ± s.e.m.; n.s., not significant, **p&lt;0.005, ***p&lt;0.0005 compared to controls using a one-way ANOVA with a Dunnett’s test. Source data is available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig1-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92376-fig1-video1.mp4" id="fig1video1"><label>Figure 1—video 1.</label><caption><title>MitoGCaMP fluorescence in the AVA neurites.</title><p>AVA neurons expressing ChRimson and mitoGCAMP were optically activated every 15 s (see ‘Localized ChRimson activation’). The video shows changes in mitoGCaMP fluorescence following optical activation at frame 30, 67, 105, and 142.5 (+Optical Activ. label in the video), as well as the region (white box) from where single-frame representative images in <xref ref-type="fig" rid="fig1">Figure 1B</xref> originated. The video was acquired at five frames per second but is rendered at 2× speed, scale bar = 5 μm. The raw, unannotated video (Video1_RAW.avi) can be found in theVideo 1—source data 1 folder located at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption></media></fig-group><p>Ca<sup>2+</sup> entry into the matrix is gated by the Ca<sup>2+</sup>-sensitive mitochondrial uniporter MCU-1 (<xref ref-type="bibr" rid="bib9">Baughman et al., 2011</xref>), which is encoded by the <italic>mcu-1</italic> gene in <italic>C. elegans</italic>. We characterized the effect of the <italic>mcu-1(ju1154</italic>) loss of function allele (<xref ref-type="bibr" rid="bib3">Álvarez-Illera et al., 2020</xref>) (hereafter called <italic>mcu-1(lf</italic>)) on activity-dependent mitochondrial Ca<sup>2+</sup> uptake by imaging mitoGCaMP in <italic>mcu-1(lf</italic>) (<xref ref-type="fig" rid="fig1">Figure 1D–F</xref>). We found that the amplitude of evoked mitoGCaMP events in <italic>mcu-1(lf</italic>) was drastically decreased compared to controls (<xref ref-type="fig" rid="fig1">Figure 1D–F</xref>). Additionally, the total mitoGCaMP activity, a combined measure of the amplitude and duration of all Ca<sup>2+</sup> events, was also reduced in <italic>mcu-1(lf</italic>) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Due to the possibility of functional compensation in <italic>mcu-1(lf</italic>), we also tested how acute treatment with the ruthenium compound Ru360, an MCU-1 blocker (<xref ref-type="bibr" rid="bib111">Woods et al., 2019</xref>), alters activity-dependent mitochondrial Ca<sup>2+</sup> uptake. Following a 10 min treatment with Ru360, we observed a decrease in the amplitude and total activity of evoked mitoGCaMP events that were similar to <italic>mcu-1(lf</italic>). To test the specificity of Ru360 for inhibiting Ca<sup>2+</sup> uptake via MCU-1, we treated <italic>mcu-1(lf</italic>) with Ru360 but did not detect additional inhibition of mitochondrial Ca<sup>2+</sup> uptake (<xref ref-type="fig" rid="fig1">Figure 1D–F</xref>). This Ru360 treatment suppressed mitochondrial Ca<sup>2+</sup> uptake out to 60 min post treatment (<xref ref-type="fig" rid="fig1">Figure 1G–I</xref>). This experiment showed that loss or inhibition of MCU-1 almost completely prevents activity-dependent mitochondrial Ca<sup>2+</sup> uptake.</p><p>While imaging mitochondrial-localized fluorescent indicators in the AVA glutamatergic interneurons, we observed that around 61% of mitochondria are in close proximity (&lt;1 μm) to clusters of surface-localized GLR-1 (quantification not shown), indicative of postsynaptic sites, that were visualized using GLR-1 tagged with pH-sensitive GFP (SuperEcliptic pHlourin, SEP) on the N-terminal (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The regulation of mitochondrial function and signaling by Ca<sup>2+</sup> appears to be integral to synaptic function and plasticity (<xref ref-type="bibr" rid="bib6">Ashrafi et al., 2020</xref>; <xref ref-type="bibr" rid="bib103">Stoler et al., 2022</xref>; <xref ref-type="bibr" rid="bib11">Billups and Forsythe, 2002</xref>; <xref ref-type="bibr" rid="bib104">Sun et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Marland et al., 2016</xref>), which led us to test if postsynaptic mitochondrial Ca<sup>2+</sup> uptake is required for normal GLR-1 localization to synapses. First, we quantified SEP::GLR-1 fluorescence in AVA dendrites in vivo to assess if the number of GLR-1 at synapses is altered by loss or inhibition of MCU-1. Initial observations revealed a dramatic increase in the fluorescence of SEP::GLR-1 puncta (indicative of synaptic sites) in <italic>mcu-1(lf</italic>) mutants (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), but not puncta density (data not shown), suggesting more GLR-1 at synaptic sites. Acute Ru360 treatment slightly, but not significantly, increased the fluorescence of SEP::GLR-1 puncta along the AVA neurite (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Next, we used fluorescence recovery after photobleaching (FRAP) of SEP::GLR-1 to measure the rate of GLR-1 recruitment to the synaptic membrane. SEP will only fluoresce when GLR-1 is positioned at the plasma membrane and is quenched while in transport vesicles or synaptic endosomes (see <xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1A</xref>). In addition, our FRAP protocol (see ‘Materials and methods’ for details) involves photobleaching a ~40–60 µm portion of the neurite proximally and distally to the imaging region that is intended to limit the influence of GLR-1 lateral diffusion in the membrane on fluorescence recovery. Thus, the relative recovery of SEP fluorescence (%FRAP rate) in a photobleached neurite is representative of GLR-1 that has been exocytosed to the membrane and the rate of GLR-1 recycled via endocytosis. The rate of SEP fluorescence recovery (without individual normalization; see ‘Materials and methods’ for analysis details) was increased more than twofold in <italic>mcu-1(lf</italic>) and slightly increased following Ru360 treatment (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). When the fluorescence at each timepoint after photobleaching is normalized to the fluorescence before photobleaching, the %FRAP is unchanged between experimental groups (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Taken together, these analyses show that loss or inhibition of MCU-1 leads to excessive recruitment of GLR-1 to synapses but proportional to the amount of GLR-1 at synapses.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Decreased mitochondrial Ca<sup>2+</sup> uptake affects transport and recruitment of GLR-1 to synapses.</title><p>(<bold>A</bold>) Single Z-plane fluorescent images of mitochondria (mito-TdTomato) and surface-localized GLR-1 (SEP::GLR-1) showing mitochondria localized at (arrows) or adjacent to (arrowheads) SEP::GLR-1 puncta. (<bold>B, D</bold>) Representative images of (<bold>B</bold>) SEP::GLR-1 (strains: FJH 214 and FJH 638) or (<bold>D</bold>) GLR-1::GFP (strains: FJH 18 and FJH 576) fluorescence before, immediately after, 8, and 16 min post photobleach (PB). (<bold>C</bold>) Fluorescence (arbitrary units = a.u.) of SEP over 16 min post PB (n = 8 animals per group). (<bold>E</bold>) Percent GFP fluorescence recovery after PB (FRAP) over 16 min (n ≥ 9 animals per group). *p&lt;0.01, ****p&lt;0.0001 using an extra sum-of-squares <italic>F</italic>-test with a Bonferroni correction. (<bold>F</bold>) 20 s representative kymographs of GLR-1::GFP movement in AVA neurite in controls (strain: FJH 18) and <italic>mcu-1(lf</italic>) (strain: FJH 576) with or without Ru360 pretreatment. Time is represented on the y-axis and distance on the x-axis. (<bold>G</bold>) Total transport events quantified from kymographs in all conditions (n &gt; 10 animals per group). (<bold>H</bold>) Representative traces of ∆F/F<sub>min</sub> of cytoplasmic GCaMP6f following optical stimulation. (<bold>I</bold>) The maximum ∆F/F<sub>min</sub> of cytoplasmic GCaMP6f events and (<bold>J</bold>) normalized total GCaMP6f activity during a 1.5 min recording with optical activation of AVA neurons every 30 s (n ≥ 10 animals per group). All scale bars = 5 µm. Data is represented as mean ± s.e.m.; n.s, not significant, ****p&lt;0.0001 compared to controls or indicated experimental group using a one-way ANOVA with a Dunnett’s test. Source data is available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Additional analysis of SEP::GLR-1 fluorescence and fluorescence recovery after photobleaching (FRAP), and velocity analysis of GLR-1 transport.</title><p>(<bold>A</bold>) SEP puncta fluorescence (a.u. = arbitrary units) in control, Ru360-treated, and <italic>mcu-1(lf</italic>) animals prior to FRAP (n ≥ 8 animals per group). (<bold>B</bold>) Percent of SEP recovery after photobleaching (FRAP) over 16 min post photobleaching in each experimental group (n ≥ 8 animals per group) from the same dataset as <xref ref-type="fig" rid="fig2">Figure 2C</xref>. n.s., not significant as determined by comparing the fitted curves using an extra sum-of-squares <italic>F</italic>-test with Bonferroni correction. (<bold>C</bold>) Average transport velocity of GLR-1 transport quantified from the same kymographs as in <xref ref-type="fig" rid="fig2">Figure 2F and G</xref> (n &gt;10 animals per group). Data is represented as mean ± s.e.m.; n.s., not significant compared to control, ****p&lt;0.0001 compared to controls or indicated experimental group using a one-way ANOVA with a Dunnett’s test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig2-figsupp1-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92376-fig2-video1.mp4" id="fig2video1"><label>Figure 2—video 1.</label><caption><title>GLR-1::GFP transport in AVA neurons.</title><p>This video shows GFP-tagged GLR-1 in the AVA neurites before photobleaching, then following photobleaching (white box shows photobleaching region; see ‘Transport imaging and analysis’) rendered to reveal GLR-1 transport, with the soma of the AVA neurons on the left and scale bar = 5 μm. The video was taken at 10 frames per second but is rendered at 60 frames per second. The raw image stream used to make this video (Video2_RAW.tif) and an annotated version showing the ROI used for cropping and rendering (white box, Video2_ROI.tif) can be found in the zipped folder Video 2—source data 1 located at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption></media></fig-group><p>The recruitment of GLR-1 to the synaptic membrane depends on the local GLR-1 reserves in synaptic endosomes (<xref ref-type="bibr" rid="bib47">Gutiérrez et al., 2021</xref>). Resupplying of these local receptor pools occurs when GLR-1-containing transport vesicles are delivered to endosomes or other local reserves (<xref ref-type="bibr" rid="bib83">Petrini et al., 2009</xref>). The delivery rate of new GLR-1 can be measured by FRAP of GLR-1::GFP (see <xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1B</xref>). In <italic>mcu-1(lf</italic>), the rate of GLR-1::GFP FRAP was decreased compared to controls but slightly increased in Ru360-treated animals (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Synaptic delivery and exocytosis of GLR-1 are dependent upon the transport of GLR-1-containing vesicles by molecular motors from the cell body where GLR-1 is predominantly synthesized. So, to better understand our results above (<xref ref-type="fig" rid="fig2">Figure 2C and E</xref>), we analyzed GLR-1 transport in <italic>mcu-1(lf</italic>) and with Ru360 treatment. To do this, we visualized individual GLR-1::GFP transport by photobleaching a section (~40 µm) of the AVA neurites (<xref ref-type="video" rid="fig2video1">Figure 2—video 1</xref>) as previously described (<xref ref-type="bibr" rid="bib55">Hoerndli et al., 2022</xref>; <xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>). Interestingly, we found that both <italic>mcu-1(lf</italic>) and Ru360 treatment decreased the amount of GLR-1 transport by ~50% (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>). Ru360 treatment of <italic>mcu-1(lf</italic>) did not further decrease the amount of GLR-1 transport compared to <italic>mcu-1(lf</italic>) alone. Mitochondrial matrix Ca<sup>2+</sup> regulates oxidative phosphorylation via several mechanisms, so <italic>mcu-1(lf</italic>) and/or Ru360 treatment could reduce GLR-1 transport indirectly by decreasing ATP production. The processivity and velocity of molecular motor movement are highly coupled to ATP availability (<xref ref-type="bibr" rid="bib93">Schnitzer et al., 2000</xref>) but the velocity of GLR-1 transport was comparable between controls and <italic>mcu-1(lf</italic>) or with Ru360 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). This suggests that ATP availability is relatively unchanged by loss or inhibition of MCU-1 or that basal rates of ATP production are sufficient to support normal transport velocities. Together, these results suggest that mitochondrial Ca<sup>2+</sup> uptake differentially regulates GLR-1 transport out of the cell body and synaptic recruitment of GLR-1.</p><p>Previous work has shown that cytoplasmic Ca<sup>2+</sup> signaling regulates transport and synaptic localization of GLR-1 (<xref ref-type="bibr" rid="bib49">Hangen et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Hoerndli et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>), so we tested if decreased mitochondrial Ca<sup>2+</sup> uptake alters the amplitude or duration of cytoplasmic Ca<sup>2+</sup> transients in dendrites following neuronal activation since this would impact downstream Ca<sup>2+</sup> signaling and synaptic recruitment of GLR-1. We expressed ChRimson and the cytoplasmic Ca<sup>2+</sup> indicator GCaMP6f in the AVA neurons in <italic>mcu-1(lf</italic>) and control animals. This approach bypasses activation by presynaptic inputs allowing direct activation of the AVA interneurons. We simultaneously optically activated the AVA neurons and recorded GCaMP6f fluorescence in <italic>mcu-1(lf</italic>) and Ru360-treated controls in the same dendritic region of the AVA neurons where GLR-1 transport and FRAP were analyzed. There were no significant changes in cytoplasmic Ca<sup>2+</sup> transients in dendrites following AVA activation with ChRimson between <italic>mcu-1(lf</italic>) or with Ru360 treatment compared to controls (<xref ref-type="fig" rid="fig2">Figure 2H–J</xref>), suggesting that loss or inhibition of MCU-1 does not drastically alter activity-dependent cytoplasmic Ca<sup>2+</sup> influx or the duration of a Ca<sup>2+</sup> event in dendrites. In other words, the loss or inhibition of MCU-1 does not seem to impact synaptic recruitment of GLR-1 by indirectly modulating cytoplasmic Ca<sup>2+</sup> signaling.</p></sec><sec id="s2-2"><title>Neuronal excitation upregulates mitoROS signaling</title><p>Our previous work has shown that ROS regulate transport and synaptic delivery of GLR-1 (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Doser and Hoerndli, 2022</xref>). To further address the mechanism by which Ca<sup>2+</sup> influx by MCU-1 modulates GLR-1, we tested if activity-dependent Ca<sup>2+</sup> uptake regulates mitoROS production. To do this, we stimulated the AVA neuron with ChRimson using the same optical activation that initiated mitochondrial Ca<sup>2+</sup> uptake (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Then, we measured ROS levels at dendritic mitochondria using a genetically encoded ratiometric ROS sensor that was localized to the outer mitochondrial membrane (mito-roGFP) (<xref ref-type="bibr" rid="bib74">Morgan et al., 2011</xref>; <xref ref-type="fig" rid="fig3">Figure 3A</xref>). We found that the duration of repetitive AVA stimulation positively correlated with the mito-roGFP fluorescence ratio (F<sub>ratio</sub>; 405/488 nm), indicating increased ROS following neuronal activation (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). The F<sub>ratio</sub> was unchanged in controls that were not treated with Retinal, which is required for optical stimulation, and subjected to the light stimulation protocol. Similar to mitoGCaMP responses, we saw diversity among dendritic mitochondria in mito-roGFP F<sub>ratios</sub> following neuronal activation of the AVA neurons (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). The frequency distribution of mito-roGFP F<sub>ratios</sub> of individual mitochondria without stimulation is unimodal (centered at 0.03) but becomes bimodal following 60 min of repetitive activation. One peak is slightly right shifted (centered at 0.05) and the other is strongly right shifted, corresponding to significantly higher mito-roGFP F<sub>ratios</sub> (centered at 0.09; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). These results suggest that mitochondria within these neurites differentially respond to activity in terms of their ROS production.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Mitochondrial reactive oxygen species (mitoROS) production is upregulated by neuronal activity and dependent on mitochondrial Ca<sup>2+</sup> uptake via MCU-1.</title><p>(<bold>A</bold>) Illustration showing transgenic expression and subcellular localization of ChRimson and mito-roGFP in the AVA neurons. (<bold>B</bold>) Representative images of mito-roGFP fluorescence in a single Z-plane when excited with 488 nm or 405 nm light following optogenetic stimulation with or without all-trans-Retinal (strain: FJH 402). (<bold>C</bold>) Mito-roGFP fluorescence ratio (405/488 nm) following 0, 5, 20, or 60 min of repetitive optical stimulation (40 μW/mm<sup>2</sup> at 33.3 mHz) with Retinal pretreatment and 60 min of repetitive optical stimulation without Retinal pretreatment (n &gt; 30 mitochondria from eight animals per group). (<bold>D, F</bold>) Representative images of mito-roGFP fluorescence in a single Z-plane when excited by 488 nm or 405 nm light following 0 or 60 min of repetitive optical stimulation with Retinal pretreatment. (<bold>E</bold>) Mito-roGFP F<sub>ratio</sub> following 0 or 60 min of repetitive optical stimulation in <italic>mcu-1(lf</italic>) (strain: FJH 706) and controls (strain: FJH 402), as well as non-Retinal-treated controls that underwent 60 min of stimulation (n ≥ 32 mitochondria from eight animals per group). Statistical comparisons are between groups and the 0 min control unless indicated by horizontal bar. (<bold>G</bold>) Mito-roGFP F<sub>ratio</sub> at 0 and 60 min following repeated optical stimulation with or without Ru360 treatment (n ≥ 38 mitochondria from eight animals per group; strain FJH 402). All scale bars = 5 µm. Data is represented as mean ± s.e.m.; n.s., not significant, ****p&lt;0.0001 compared to controls or indicated experimental group using a one-way ANOVA with a Dunnett’s test. Source data is available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Additional analysis of mito-roGFP reveals differential activity-induced reactive oxygen species (ROS) production at dendritic mitochondria.</title><p>(<bold>A</bold>) Representative image of the diversity observed in mito-roGFP F<sub>ratios</sub> (emission due to 405 nm excitation/emission due to 488 nm excitation) in a portion of the AVA following repetitive optical activation. (<bold>B</bold>) The frequency of observed mito-roGFP F<sub>ratios</sub> expressed as a percent of the total observed F<sub>ratios</sub> (binned every 0.02) from the same dataset as <xref ref-type="fig" rid="fig3">Figure 3C</xref>. (<bold>C</bold>) The complete dataset from <xref ref-type="fig" rid="fig3">Figure 3E</xref> showing mito-roGFP F<sub>ratio</sub> (Ex405/Ex488) observed following 0, 5, 20, or 60 min of repetitive optical stimulation in controls and <italic>mcu-1(lf</italic>) (n &gt; 34 mitochondria from eight animals per group). (<bold>D</bold>) The complete dataset from <xref ref-type="fig" rid="fig3">Figure 3G</xref> mito-roGFP F<sub>ratios</sub> observed at 0, 5, 20, or 60 min of repetitive light stimulation in Ru360-treated animals compared to controls (n &gt; 38 mitochondria from eight animals per group). Data is represented as mean ± s.e.m.; n.s., not significant, **p&lt;0.005, ***P&lt;0.0005, ****p&lt;0.0001 compared to non-activated controls or indicated experimental group using a one-way ANOVA with a Dunnett’s test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig3-figsupp1-v2.tif"/></fig></fig-group><p>So, does this activity-dependent upregulation of mitoROS production require Ca<sup>2+</sup> uptake through MCU-1? Expression of ChRimson and mito-roGFP in <italic>mcu-1(lf</italic>) revealed that the loss of MCU-1 prevented activity-induced increases in the mito-roGFP F<sub>ratio</sub> even after 60 min of repetitive optical activation (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Pretreatment with Ru360 prior to optical activation similarly prevented the activity-induced increase in mito-roGFP F<sub>ratio</sub> (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). In summary, both the acute pharmacological inhibition and genetic loss of MCU-1 prevented activity-dependent upregulation of mitoROS production. Since optical activation is artificial and does not rely on synaptic transmission, it is possible that mitoROS production is not upregulated by natural neuronal activation. To address this, we took advantage of the well-defined circuitry in <italic>C. elegans</italic> and designed an experiment to activate a subset of mechanosensory neurons that detect physical touch and vibration (<xref ref-type="bibr" rid="bib91">Schafer, 2015</xref>) and provide excitatory input to AVA neurons. This involved repetitively activating presynaptic mechanosensory neurons with vibration caused by dropping culture plates containing freely behaving worms from a short distance (~5 cm) onto the bench top every 30 s for a duration of 5 or 10 min. Then, worms were mounted for imaging to assess the F<sub>ratio</sub> of mito-roGFP. The mito-roGFP F<sub>ratio</sub> was slightly increased following 5 min and significantly increased by 10 min of repetitive mechano-stimulation (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>), indicating that mitoROS production is also increased by native means of neuronal activation.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Photoactivation (PA) of mitochondria localized KillerRed results in physiological elevations in mitochondrial reactive oxygen species (mitoROS).</title><p>(<bold>A</bold>) Representative images of mito-roGFP fluorescence in a single Z-plane when excited with 488 nm or 405 nm light following 0, 5, or 10 min of repetitive mechano-stimulation (strain: FJH 402). (<bold>B</bold>) Quantification of the average mito-roGFP F<sub>ratio</sub> following 0, 5, or 10 min of repetitive mechano-stimulation (n &gt; 50 mitochondria from eight animals per condition). (<bold>C</bold>) Illustration depicting subcellular localization of mitoKR and mito-roGFP within the AVA neurites. (<bold>D</bold>) Representative fluorescent images demonstrating the co-localization of mitoKR and mito-roGFP within the AVA neurite (strain: FJH 416). (<bold>E</bold>) Representative fluorescent images of mito-roGFP when excited by 405 nm or 488 nm light following 0, 15, or 30 s of PA directed at 1–3 mitochondria (green box). Localization of PA was considered to be spatially specific enough that neighboring mitochondria (gray box) were not exposed to the PA stimulus. (<bold>F</bold>) The mito-roGFP F<sub>ratio</sub> in mitochondria that were (green bars; n = 8 mitochondria from eight worms per group) or were not (white bars; n &gt; 15 mitochondria from eight worms) targeted for PA as well as in worms without any additional optical activation (gray bars). n &gt; 20 mitochondria from eight worms per group; *p&lt;0.05, **p&lt;0.005 using a paired <italic>t</italic>-test. No significant difference between the no light controls and the neighboring mitochondria (one-way ANOVA with Dunnett’s test). (<bold>G</bold>) Representative fluorescent images of mito-roGFP excited by 488 nm or 405 nm light with 0, 5, or 10 min of consistent light (567 nm; 0.025 mW/mm<sup>2</sup>) for global PA of mitoKR. (<bold>H</bold>) Quantification of mito-roGFP fluorescence ratio (F<sub>ratio</sub>, Ex405/Ex488nm) for each group (n &gt; 32 mitochondria from eight animals per group). All scale bars = 5 µm. Data is represented as mean ± s.e.m.; *p&lt;0.05, n.s., not significant using a one-way ANOVA with a Dunnett’s test. Source data is available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig4-v2.tif"/></fig></sec><sec id="s2-3"><title>Using the photosensitizer KillerRed for artificial ROS production at dendritic mitochondria</title><p>We next wanted to address the possible role of ROS production at dendritic mitochondria in regulating the multistep process required for synaptic recruitment of GLR-1 in a cell-specific manner independent of mitochondrial Ca<sup>2+</sup> handling. To this end, we expressed the photosensitizer KillerRed that produces ROS upon photoactivation (PA) with green light (<xref ref-type="bibr" rid="bib18">Bulina et al., 2006</xref>). In addition, we localized KillerRed to mitochondria (mitoKR) by anchoring it to the outer mitochondrial membrane with the localization tag TOMM20 (<xref ref-type="bibr" rid="bib15">Braeckman et al., 2016</xref>). First, we co-expressed mitoKR with mito-roGFP (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>) for optimization of a PA protocol that would artificially induce elevations in ROS levels (within the physiological range) at a subset of synapses (local, <xref ref-type="fig" rid="fig4">Figure 4E and F</xref>) or throughout the AVA neuron (global, <xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). To test our local PA protocol, we used a microscopy setup that was equipped for targeted illumination (see ‘Materials and methods’) allowing us to direct a green LED to a small portion (~10 µm) of the AVA neurites containing 1–3 mitochondria for 15 or 30 s (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). The mito-roGFP F<sub>ratio</sub> was increased in the mitochondria that were targeted for 15 or 30 s of PA when compared to non-activated controls as well as neighboring mitochondria not targeted for PA (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Local PA of mitoKR increased the mito-roGFP F<sub>ratio</sub> by 2×, which is comparable to the effect of short-term AVA activation by ChRimson (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) and mechano-stimulation (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>) on mitoROS production. In addition, local PA of mitoKR had no effect on the amount of GLR-1 transport (data not shown) or on GLR-1 transport velocity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Both of these processes rely on intact microtubules and normal microtubule dynamics that are sensitive to prolonged elevations in ROS (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>; <xref ref-type="bibr" rid="bib110">Wilson and González-Billault, 2015</xref>; <xref ref-type="bibr" rid="bib23">Debattisti et al., 2017</xref>) and oxidative stress (<xref ref-type="bibr" rid="bib42">Goldblum et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Drum et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Fang et al., 2012</xref>). In other words, local PA of mitoKR results in <italic>physiological</italic> elevations in mitoROS production.</p><p>Secondly, we optimized a protocol to modestly increase ROS production at mitochondria throughout AVA interneurons. More specifically, whole-cell PA of mitoKR was achieved by illuminating freely behaving worms for 5 or 10 min. We used mito-roGFP to measure the resultant ROS increase at mitochondria from whole-cell PA and observed a slight increase in the average mito-roGFP F<sub>ratio</sub> after 5 min of whole-cell PA and a significant increase in the F<sub>ratio</sub> following a 10 min whole-cell PA (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). Although not significantly increased from the unstimulated control, the 5 min PA increased the F<sub>ratio</sub> of mito-roGFP to 0.4, which is similar to the mito-roGFP F<sub>ratio</sub> following 5 min of repetitive ChRimson activation (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) or mechano-stimulation of AVA (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). Therefore, we chose to do subsequent experiments using a whole-cell PA duration of 5 min. Finally, this global mitoKR activation protocol did not affect overall GLR-1 transport velocity (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>), further supporting our choice of these conditions as relevant for signaling but non-toxic.</p></sec><sec id="s2-4"><title>Mitochondrial ROS signaling regulates synaptic recruitment of GLR-1</title><p>Once we established non-toxic conditions for local (2–3 mitochondria) and global (entire AVA neuron) mitoKR activation, we proceeded to test the effect of cell-specific and subcellular mitoROS signaling on synaptic GLR-1 recruitment. First, we used our local mitoKR protocol (15 s) to activate 2–3 mitochondria prior to assessing synaptic recruitment of GLR-1 via FRAP of SEP::GLR-1 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). These experiments required the generation of new transgenic animals expressing SEP::GLR-1 in AVA with (strain: FJH 582) and without mitoKR (strain: FJH 635; see Appendix 1—key resources table). Interestingly, local PA dramatically decreased SEP::GLR-1 FRAP in mitoKR-expressing worms compared to controls (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). The FRAP rate of non-activated mitoKR worms was significantly decreased compared to controls, but to a lesser extent than with PA (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). This is likely due to activation of mitoKR during imaging of SEP fluorescence. This dramatic downregulation of GLR-1 synaptic recruitment due to localized artificial mitoROS production could be caused by altered delivery of GLR-1-containing transport vesicles. When we assessed GLR-1 delivery via FRAP of GLR-1::GFP following local PA of mitoKR, we observed that PA of mitoKR decreased the rate of GLR-1::GFP FRAP in worms expressing mitoKR in comparison to controls lacking mitoKR (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>), as well as mitoKR-expressing animals without PA (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). These results suggest that the delivery and retention of GLR-1 to synaptic sites are negatively regulated by local mitoROS production.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Mitochondrial reactive oxygen species (mitoROS) downregulates the recruitment of GLR-1 to synapses.</title><p>(<bold>A</bold>) Diagram of experimental procedure followed for (<bold>B–D</bold>) (see ‘Materials and methods’). (<bold>B, D</bold>) Representative images of (<bold>B</bold>) SEP::GLR-1 (strains: FJH 635 and FJH 582) or (<bold>D</bold>) GLR-1::GFP (strains: FJH 18 and FJH 555) fluorescence before, immediately after, 8, and 16 min after local photoactivation (PA) and photobleach (PB). (<bold>C, E</bold>) Percent SEP (<bold>C</bold>) or GFP (<bold>E</bold>) fluorescence recovery after PB (FRAP) over 16 min after local PA and PB (n ≥ 7 animals per group). ***p&lt;0.0005, ****p&lt;0.0001 using an extra sum-of-squares <italic>F</italic>-test with a Bonferroni correction. (<bold>F</bold>) Diagram of experimental procedure followed for (<bold>G, H</bold>) (see ‘Materials and methods’). (<bold>G</bold>) 30 s representative kymographs of GLR-1::GFP movement in the AVA with or without global PA. (<bold>H</bold>) Total number of transport events per minute quantified from 50-s-long kymographs (n = 8 animals per +mitoKR group, and n = 4 per control group). All scale bars = 5 µm. Data is represented as mean ± s.e.m.; *p&lt;0.05 compared to controls or indicated experimental group using a one-way ANOVA. Source data is available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Post hoc velocity analyses of GLR-1 transport with mitoKR activation and non-photoactivation (non-PA) fluorescence recovery after photobleaching (FRAP) controls.</title><p>(<bold>A, B</bold>) Average transport velocity of GLR-1 transport (<bold>A</bold>) within (+Local PA) or outside (-Local PA) of mitoKR PA region (n = 8 animals for +mitoKR group, and n = 4 for controls) or (<bold>B</bold>) from the same kymographs as in <xref ref-type="fig" rid="fig5">Figure 5G and H</xref> (n = 8 animals per +mitoKR group, and n = 4 per control group). Each comparison is nonsignificant using a one-way ANOVA with a Dunnett’s correction for multiple comparisons. All data is represented as mean ± s.e.m. (<bold>C, D</bold>) Percent SEP (<bold>C</bold>) or GFP (<bold>D</bold>) FRAP over 16 min post-photobleaching and without PA in controls or worms expressing mitoKR in the AVA neurons (n ≥ 7 animals per group) from the same dataset as <xref ref-type="fig" rid="fig5">Figure 5C and D</xref>, respectively. ****p&lt;0.0001, n.s., not significant as determined by comparing the fitted curves using an extra sum-of-squares <italic>F</italic>-test with a Bonferroni’s correction for multiple comparisons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig5-figsupp1-v2.tif"/></fig></fig-group><p>We speculated that ROS production by mitoKR could also impact transport of GLR-1 in a similar fashion to global ROS elevations shown previously (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>). To test this hypothesis, we subjected animals to our global mitoKR activation protocol prior to imaging GLR-1 transport (<xref ref-type="fig" rid="fig5">Figure 5F</xref>) and found that cell-wide PA of mitoKR reduces the number of transport events (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>). These results coincide with our previous work showing that systemic elevations in ROS decrease export of GLR-1 out of the cell body (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>) and suggest that the mitochondria are a major source of the ROS involved in this regulation.</p><p>In summary, our results demonstrate that dendritic mitochondria take up Ca<sup>2+</sup> in response to neuronal activity, leading to an upregulation in ROS production at mitochondria. We also show that cell-specific ROS production at mitochondria and loss or inhibition of MCU had opposite effects on GLR-1 recruitment in AVA neurites (<xref ref-type="fig" rid="fig2">Figures 2C</xref> and <xref ref-type="fig" rid="fig5">5C</xref>), so we hypothesized that local Ca<sup>2+</sup> uptake by mitochondria and mitoROS production regulate the amount of GLR-1 at the plasma membrane through the same signaling pathway. To test this, we subjected control or mitoKR-expressing worms to an acute Ru360 treatment, mounted them for imaging, and photoactivated a region of the AVA neurites prior to carrying out the FRAP protocol for SEP::GLR-1 (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This technique allowed us to acutely bypass mitochondrial Ca<sup>2+</sup> uptake and artificially induce ROS production at dendritic mitochondria in order to test if mitoROS is sufficient to downregulate synaptic recruitment of GLR-1 in the AVA neurites. In this experiment, Ru360 treatment increased SEP::GLR-1 %FRAP. This result is inconsistent with the effect of Ru360 on the %FRAP of SEP::GLR-1 presented in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, but we speculate that this discrepancy may be due to lower basal expression of SEP::GLR-1 in these strains than those used previously (strains FJH 314 and FJH 638 used in <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>; data not shown). Local PA of mitoKR decreased the recovery rate, and when combined with Ru360 treatment, the %FRAP of SEP::GLR-1 was slightly delayed, but the relative fluorescence recovery after 16 min post-photobleach was nearly identical to local PA of mitoKR alone (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>). Interestingly, Ru360 treatment of mitoKR-expressing worms without PA had a %FRAP rate that was comparable to the non-activated, untreated mitoKR group (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Since artificial mitoROS production was able to occlude the effect of Ru360 on SEP::GLR-1 FRAP, these results support that mitoROS is necessary and sufficient for downregulating recruitment of GLR-1 to synapses. Contrary to synaptic GLR-1 recruitment, somatic export of GLR-1 is paradoxically reduced by both artificial mitoROS production and inhibition of MCU-1. To test if mitoROS and mitochondrial Ca<sup>2+</sup> uptake regulate GLR-1 transport out of the cell body via the same mechanism, we combined acute Ru360 treatment with 5 min of whole-cell PA of mitoKR prior to imaging GLR-1 transport (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Both acute Ru360 treatment and whole-cell PA of mitoKR decreased the number of GLR-1 transport events to a similar extent (<xref ref-type="fig" rid="fig2">Figures 2G</xref> and <xref ref-type="fig" rid="fig5">5H</xref>). When combined, the amount of GLR-1 transport was significantly decreased compared to Ru360 treatment alone and modestly decreased compared to mitoKR activation (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). Ru360 treatment of mitoKR-expressing worms in the absence of PA had no additional effect on the amount of GLR-1 transport compared to untreated mitoKR-expressing worms (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). The compounding effect of mitoROS production and decreased mitochondrial Ca<sup>2+</sup> uptake indicates that mitoROS signaling and mitochondrial Ca<sup>2+</sup> uptake modulate GLR-1 transport via parallel regulatory pathways. This contrasts our observations of a Ca<sup>2+</sup>-dependent mitoROS signaling mechanism in the regulation of GLR-1 recruitment to synapses (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) and suggests that mitochondrial activation and signaling vary based on subcellular location. Taken altogether, our results reveal a physiological mitoROS signaling mechanism that is initiated by activity-dependent Ca<sup>2+</sup> uptake and downregulates GLR-1 recruitment to synapses.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Regulation of synaptic recruitment of GLR-1 by mitochondrial reactive oxygen species (mitoROS) requires Ca<sup>2+</sup> uptake via MCU-1.</title><p>(<bold>A</bold>) Diagram of experimental procedure in (<bold>B, C</bold>) (see ‘Materials and methods’). (<bold>B</bold>) Representative images of SEP fluorescence prior to, immediately after, and at 8 and 16 min post photobleach (PB). (<bold>C</bold>) Percent SEP fluorescence recovery after photobleaching (FRAP) throughout 16 min post PB in controls (strain: FJH 635) or mitoKR-expressing animals (strain: FJH 582) ± Ru360 treatment with photoactivation (PA) (n = 6 animals per group). **p&lt;0.005, ****p&lt;0.0001 using an extra sum-of-squares <italic>F</italic>-test with a Bonferroni correction. (<bold>D</bold>) Diagram of experimental procedure for (<bold>E, F</bold>) (see ‘Materials and methods’). (<bold>E</bold>) 30-s-long representative kymographs of GLR-1 transport in controls (strain: FJH 18) or mitoKR-expressing animals (strain: FJH 555) ± Ru360 treatment with PA. (<bold>F</bold>) Total number of transport events quantified from 50-s-long kymographs (n ≥ 10 animals per group). All scale bars = 5 µm. Data is represented as mean ± s.e.m.; n.s., not significant, **p&lt;0.005, ****p&lt;0.0001 compared to controls or indicated experimental group using a one-way ANOVA. Source data is available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Additional non-photoactivation (non-PA) SEP fluorescence recovery after photobleaching (FRAP) and transport controls.</title><p>(<bold>A</bold>) Percent of SEP FRAP in the same experimental groups as in <xref ref-type="fig" rid="fig6">Figure 6C</xref> (n ≥ 5 animals per group). (<bold>B</bold>) Number of GLR-1 transport events quantified from 50-s-long kymographs (from <xref ref-type="fig" rid="fig6">Figure 6E and F</xref>) in controls (n = 10 animals per group) with local PA as well as mitoKR-expressing worms with or without Ru360 treatment but without PA (n = 5 animals per group). Data is represented as mean ± s.e.m.; n.s., not significant, ***p&lt;0.0005 compared to controls using a one-way ANOVA with a Dunnett’s test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig6-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Taken together, our experimental results outline a possible novel activity-dependent mitochondrial signaling mechanism that negatively regulates excitatory synapse function. Our data suggest that mitochondrial Ca<sup>2+</sup> uptake and ROS production are involved in different regulatory mechanisms based on subcellular location and/or process. In the cell body, mitochondrial Ca<sup>2+</sup> uptake and ROS production influence GLR-1 export via parallel mechanisms (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Our results indicate that Ca<sup>2+</sup> influx through MCU-1 is required in the neuronal cell body for normal GLR-1 transport, suggesting that mitochondrial Ca<sup>2+</sup> positively regulates transport via unknown indirect signaling mechanisms (maybe ATP production, orange dashed arrow in <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Independent of MCU-1 function, mitoROS downregulates somatic export of GLR-1 (red dashed inhibition arrow in <xref ref-type="fig" rid="fig7">Figure 7A</xref>), and as suggested by our previous work, this probably occurs by redox regulation of proteins involved in this process (<xref ref-type="bibr" rid="bib54">Hoerndli et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>). At postsynaptic sites, mitochondrial Ca<sup>2+</sup> uptake and ROS production regulate the recruitment (and perhaps recycling) of GLR-1 to the synaptic membrane via a linear signaling mechanism (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). We speculate that neuronal activation leads to mitochondrial Ca<sup>2+</sup> uptake via MCU-1, causing an increase in mitoROS that indirectly downregulates synaptic recruitment of AMPARs (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The effect of mitoROS signaling on AMPAR recruitment to synapses appears to be due to the compounding effect of decreased transport out of the cell body, synaptic delivery, as well as exocytosis of AMPARs to the synaptic membrane (<xref ref-type="fig" rid="fig5">Figure 5</xref>). This negative regulation by mitoROS may be a homeostatic mechanism that is important for the prevention of excessive synaptic strengthening and the excitotoxicity that could result without this regulatory mechanism. This model (<xref ref-type="fig" rid="fig7">Figure 7</xref>) is in alignment with our overall experimental results. However, further investigation about local GLR-1 trafficking in the context of our proposed model, and the molecular players involved, will be required to test this mechanism.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Proposed model.</title><p>In neurons, increased cytoplasmic Ca<sup>2+</sup> due to activity-dependent opening of AMPARs, NMDARs, and voltage-gated calcium channels (VGCCs) results in mitochondrial Ca<sup>2+</sup> uptake via voltage-dependent anion channels (VDACs) at the outer mitochondrial membrane and further entry into the mitochondrial matrix via MCU. Once in the matrix, Ca<sup>2+</sup> can directly and indirectly upregulate mitochondrial respiration from which reactive oxygen species (ROS) is a by-product. The increased ROS can escape into the cytoplasm in the form of H<sub>2</sub>O<sub>2</sub> and contribute to ROS signaling. This research points toward differential roles for and interactions between MCU and mitochondrial ROS (mitoROS) in regulating the subcellular trafficking of GLR-1. The results presented here indicate that (<bold>A</bold>) in the neuronal soma, where GLR-1 is synthesized and then exported, MCU-1 function indirectly promotes (dashed orange arrow) GLR-1 export, whereas mitoROS indirectly inhibits (dashed red inhibition arrow) it by acting on undetermined proteins. Alternatively, our data suggest that at postsynaptic sites, (<bold>B</bold>) ROS signaling resulting from Ca<sup>2+</sup> uptake via MCU may target and modulate the function of undetermined proteins (dashed red line) that regulate the recruitment of AMPARs from transport vesicles or intracellular reserves (i.e., synaptic endosomes, left organelle) to the synaptic membrane and/or their synaptic retention.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-fig7-v2.tif"/></fig><sec id="s3-1"><title>Mitochondrial calcium handling in synaptic function and plasticity</title><p>Buffering of cytoplasmic Ca<sup>2+</sup> by mitochondria is thought to shape the spatiotemporal dynamics of Ca<sup>2+</sup> signaling and upregulate mitochondrial output to meet energy demands (<xref ref-type="bibr" rid="bib31">Duchen, 2000</xref>). Fine regulation of synaptic Ca<sup>2+</sup> is particularly important because synaptic function and plasticity rely on a multitude of Ca<sup>2+</sup>-dependent signaling pathways that are all sensitive to the amplitude and duration of elevated Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib76">Nakahata and Yasuda, 2018</xref>). It is known that Ca<sup>2+</sup> handling by presynaptic mitochondria modulates various presynaptic mechanisms central to synaptic transmission and plasticity, including synaptic vesicle recycling (<xref ref-type="bibr" rid="bib11">Billups and Forsythe, 2002</xref>; <xref ref-type="bibr" rid="bib71">Marland et al., 2016</xref>) and release probability (<xref ref-type="bibr" rid="bib6">Ashrafi et al., 2020</xref>; <xref ref-type="bibr" rid="bib104">Sun et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Lee et al., 2007</xref>; <xref ref-type="bibr" rid="bib24">Devine et al., 2022</xref>). Electron microscopy has revealed that mitochondria in the pre- and postsynaptic compartments of excitatory synapses differ in both size and electron density (<xref ref-type="bibr" rid="bib39">Freeman et al., 2017</xref>), hinting that postsynaptic mitochondrial specialization is different from their presynaptic counterparts. However, only a few recently published studies have investigated if and how mitochondrial Ca<sup>2+</sup> handling in dendrites regulates synaptic function or plasticity (<xref ref-type="bibr" rid="bib46">Groten and MacVicar, 2022</xref>; <xref ref-type="bibr" rid="bib80">O’Hare et al., 2022</xref>), and none have assessed the direct link between mitochondrial signaling and postsynaptic function in healthy neurons.</p><p>Postsynaptic plasticity mechanisms are also highly sensitive to the concentration and duration of elevated Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib57">Huganir and Nicoll, 2013</xref>; <xref ref-type="bibr" rid="bib21">Citri and Malenka, 2008</xref>), so Ca<sup>2+</sup> uptake by postsynaptic mitochondria could shape Ca<sup>2+</sup> events, and therefore synaptic transmission (<xref ref-type="bibr" rid="bib80">O’Hare et al., 2022</xref>). The importance of postsynaptic mitochondria for synaptic function could also be inferred from the decreased presence of synaptic mitochondria in Alzheimer’s and Parkinson’s disease that is observed before synaptic dysfunction (<xref ref-type="bibr" rid="bib96">Sheng, 2014</xref>). Interestingly, mitochondrial transport in neurites is regulated by relative Ca<sup>2+</sup> levels such that mitochondria deposition occurs at regions of high Ca<sup>2+</sup>, such as at pre- and postsynaptic sites (<xref ref-type="bibr" rid="bib96">Sheng, 2014</xref>). If mitochondrial Ca<sup>2+</sup> buffering truly contributes to cytoplasmic Ca<sup>2+</sup> signaling, then one would expect an increase in cytoplasmic Ca<sup>2+</sup> levels when mitochondrial Ca<sup>2+</sup> uptake is diminished. It has been shown that loss of MCU-1 increases the amplitude and/or duration of cytoplasmic Ca<sup>2+</sup> events in both invertebrate and vertebrate neurons (<xref ref-type="bibr" rid="bib46">Groten and MacVicar, 2022</xref>; <xref ref-type="bibr" rid="bib12">Bisbach et al., 2020</xref>; <xref ref-type="bibr" rid="bib78">Nichols et al., 2017</xref>). However, we did not detect a significant change in activity-dependent Ca<sup>2+</sup> influx in the AVA neuron’s cytoplasm due to loss or inhibition of MCU-1 (<xref ref-type="fig" rid="fig2">Figure 2H–J</xref>). This discrepancy may be due to GCaMP6f’s high affinity for Ca<sup>2+</sup> occluding slight changes in cytoplasmic Ca<sup>2+</sup>. Alternatively, mitochondrial Ca<sup>2+</sup> uptake in AVA neurons, and perhaps <italic>C. elegans</italic> neurons in general, may be less reliant on MCU-1 function. It is also important to note that in our hands the loss or pharmacological inhibition of MCU-1 did not completely abolish mitochondrial Ca<sup>2+</sup> uptake. However, our observations are consistent with previous studies in which MCU-1 was conditionally or completely knocked out (<xref ref-type="bibr" rid="bib3">Álvarez-Illera et al., 2020</xref>; <xref ref-type="bibr" rid="bib48">Hamilton et al., 2018</xref>).</p><p>In addition to the importance of mitochondrial Ca<sup>2+</sup> buffering for cytoplasmic signaling, there are many Ca<sup>2+</sup>-dependent processes within mitochondria. First, mitochondrial Ca<sup>2+</sup> uptake can upregulate OXPHOS, and therefore ATP production, via several direct and indirect mechanisms (<xref ref-type="bibr" rid="bib90">Rossi et al., 2019</xref>). For example, Ca<sup>2+</sup> binds to and modulates the activity of multiple tricarboxylic acid cycle enzymes (<xref ref-type="bibr" rid="bib87">Rizzuto et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Giorgi et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">O’Hare et al., 2022</xref>), which upregulates production of the OXPHOS substrates NADH and FAD2 to indirectly impact ATP and ROS production. Ca<sup>2+</sup> can also more directly upregulate OXPHOS by binding to components of the electron transport chain and ATP synthase (<xref ref-type="bibr" rid="bib87">Rizzuto et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Giorgi et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">O’Hare et al., 2022</xref>). It is possible that loss or inhibition of MCU-1 prevents activity-dependent upregulation of ATP that may indirectly impact endergonic mechanisms, including GLR-1 transport, delivery, and exocytosis (<xref ref-type="bibr" rid="bib92">Schnitzer and Block, 1997</xref>; <xref ref-type="bibr" rid="bib50">Hanley, 2007</xref>; <xref ref-type="bibr" rid="bib5">Araki et al., 2010</xref>). However, our observations of upregulated GLR-1 delivery and exocytosis when MCU-1 is mutated or inhibited (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) suggest that when mitochondrial Ca<sup>2+</sup> uptake is decreased, ATP levels remain sufficient for local GLR-1 trafficking. Secondly, since ROS are a by-product of OXPHOS, Ca<sup>2+</sup> uptake can upregulate ROS production via several Ca<sup>2+</sup>-dependent mechanisms (<xref ref-type="bibr" rid="bib44">Görlach et al., 2015</xref>). In fact, activity-induced mitoROS production via an MCU-1-dependent mechanism has been described in <italic>C. elegans</italic> in epidermal wound healing (<xref ref-type="bibr" rid="bib112">Xu and Chisholm, 2014</xref>). There is also evidence from in vitro studies in various human cell lines that MCU-dependent mitoROS signaling occurs in pathophysiological contexts such as during inflammation or hypoxia (<xref ref-type="bibr" rid="bib25">Dong et al., 2017</xref>). Lastly, mitochondrial Ca<sup>2+</sup> uptake appears to be central to the pathophysiological plasticity mechanism that underlies hyperalgesia (<xref ref-type="bibr" rid="bib60">Kim et al., 2011</xref>). However, this work, in addition to these previous studies, prompts more questions than it answers regarding postsynaptic roles of Ca<sup>2+</sup>-dependent mitoROS production.</p></sec><sec id="s3-2"><title>Regulation of AMPAR trafficking by mitochondrial ROS signaling</title><p>The characteristics of ROS production and methods of action make them a diverse messenger molecule in various cell types, especially in the brain where metabolic activity and antioxidant mechanisms are higher than that in other tissues (<xref ref-type="bibr" rid="bib13">Biswas et al., 2022</xref>; <xref ref-type="bibr" rid="bib106">Vicente-Gutiérrez et al., 2021</xref>). ROS signaling can be localized and compartmentalized due to the localization of ROS sources such as at the plasma membrane via NADPH oxidase or at mitochondria that is balanced by rapid cytoplasmic ROS scavenging (<xref ref-type="bibr" rid="bib79">Niemeyer et al., 2021</xref>; <xref ref-type="bibr" rid="bib98">Sies, 2017</xref>). This is estimated to limit ROS diffusion to around 1 µm from its source (<xref ref-type="bibr" rid="bib68">Lim et al., 2015</xref>). Reversible protein oxidation by ROS is reminiscent of phosphorylation in that it can regulate protein folding, activation, and interactions (<xref ref-type="bibr" rid="bib73">Miseta and Csutora, 2000</xref>). Interestingly, the proportion of oxidizable protein residues is increased fourfold in mammals compared to prokaryotes, suggesting that ROS signaling may contribute to organismal complexity (<xref ref-type="bibr" rid="bib41">Go and Jones, 2013</xref>).</p><p>Although mitochondria are regarded as the predominant source of ROS, there has been very little investigation of physiological mitoROS signaling in neurons in vivo. Recently, however, mitoROS production was shown to promote secretion of a neuropeptide from sensory neurons in <italic>C. elegans,</italic> which activates antioxidant mechanisms in distal tissues (<xref ref-type="bibr" rid="bib58">Jia and Sieburth, 2021</xref>). There are also a few studies that demonstrate the functional relevance and versatility of mitoROS signaling in vertebrate neurons and their circuitry (<xref ref-type="bibr" rid="bib8">Bao et al., 2009</xref>; <xref ref-type="bibr" rid="bib1">Accardi et al., 2014</xref>). Our results support an important mitochondrial signaling role and suggest a mechanism in which activity-dependent mitoROS production can regulate AMPAR recruitment. A comprehensive understanding of this mechanism would require systematically analyzing how protein oxidation alters the functionality of key players that regulate AMPAR delivery and recruitment to synapses.</p><p>There are several oxidizable candidate proteins and signaling molecules that regulate synaptic recruitment of AMPARs in neurons. Two major components of the Ca<sup>2+</sup>-signaling cascade that positively regulate AMPAR transport are calmodulin (CaM) and Ca<sup>2+</sup>/CaM-dependent protein kinase II (CaMKII) (<xref ref-type="bibr" rid="bib49">Hangen et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Hoerndli et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>), which are functionally regulated by oxidation. CaM has two conserved methionines, and when oxidized, the binding and activation of CaM to CaMKII are reduced (<xref ref-type="bibr" rid="bib88">Robison et al., 2007</xref>). When CaMKII is in its active Ca<sup>2+</sup>/CaM-bound conformation, oxidation of the regulatory domain enhances kinase activity (<xref ref-type="bibr" rid="bib33">Erickson et al., 2008</xref>). Alternatively, when CaMKII is inactive, oxidation within the CaM binding domain prevents association of Ca<sup>2+</sup>/CaM with CaMKII (<xref ref-type="bibr" rid="bib64">Konstantinidis et al., 2020</xref>). At postsynaptic sites, recycling of AMPARs is regulated in a CaM/CaMKII-dependent manner, meaning redox modification of these proteins can also influence AMPAR exocytosis and endocytosis at synapses (<xref ref-type="bibr" rid="bib10">Bayer and Schulman, 2019</xref>). Other proteins that regulate this process include protein kinase C (PKC) (<xref ref-type="bibr" rid="bib14">Boehm et al., 2006</xref>) and the PDZ domain-containing scaffold protein interacting with C kinase 1 (PICK-1) (<xref ref-type="bibr" rid="bib38">Fiuza et al., 2017</xref>). Activation of PKC following synaptic activation increases AMPAR insertion at synaptic membranes (<xref ref-type="bibr" rid="bib86">Ren et al., 2013</xref>), whereas PICK-1 regulates AMPAR endocytosis (<xref ref-type="bibr" rid="bib38">Fiuza et al., 2017</xref>). Interestingly, ROS signaling can bidirectionally modulate PKC activity (<xref ref-type="bibr" rid="bib101">Steinberg, 2015</xref>) and oxidation of PICK-1 prevents its association with the synaptic membrane (<xref ref-type="bibr" rid="bib97">Shi et al., 2010</xref>). Although the effect of PICK-1 oxidation on synaptic expression of AMPARs has not been characterized, there is evidence that this redox mechanism regulates glutamatergic transmission and is protective during oxidative stress (<xref ref-type="bibr" rid="bib108">Wang et al., 2015</xref>). Thus, the current study opens the door to other questions regarding redox regulation of synaptic function and plasticity.</p><p>In contrast to the regulation of synaptic recruitment of AMPARs by mitoROS signaling (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>), we observed a compounding effect of MCU-1 inhibition and artificial mitoROS production on AMPAR export from the cell body (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). These results suggest that AMPAR transport out of the cell body is regulated by mitochondrial Ca<sup>2+</sup> handling and mitoROS production via two parallel signaling pathways. Since somatic mitochondria are morphologically distinct from their dendritic and axonal counterparts (<xref ref-type="bibr" rid="bib67">Lee et al., 2018</xref>), it is possible that they are functionally different as well. Altogether, these results open the door to questions regarding how functional diversity among mitochondria may allow mitochondrial signaling to differentially regulate signaling pathways based on subcellular location.</p></sec><sec id="s3-3"><title>Implications and conclusion</title><p>Synaptic diversity is thought to enhance the computing power of the nervous system allowing for complex behaviors, a broad range of emotional states, and nearly endless memory storage. Interestingly, the proteomes of synaptic and non-synaptic mitochondria suggest that synaptic diversity may be enhanced by their resident mitochondria (<xref ref-type="bibr" rid="bib100">Stauch et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Graham et al., 2017</xref>). The proteomes of synaptic mitochondria allow for specialized functions, including activity-dependent regulation of ATP production and discrete Ca<sup>2+</sup> handling abilities (<xref ref-type="bibr" rid="bib37">Faria-Pereira and Morais, 2022</xref>; <xref ref-type="bibr" rid="bib17">Brown et al., 2006</xref>). The functional significance of enhanced energy capability and Ca<sup>2+</sup> handling has been assessed for presynaptic mitochondria, but not in the context of postsynaptic sites. Here, we provide data indicating that postsynaptic mitochondria are functionally diverse and play a novel signaling role in regulating postsynaptic function.</p><p>In conclusion, we present evidence for a novel role of mitochondria in regulating the number of AMPARs at the synaptic membrane. This study proposes a model in which Ca<sup>2+</sup> signaling regulates mitoROS production differentially at the soma and synapses, providing a means of negative regulation of synaptic excitability in a way that may be important for synaptic homeostasis and prevention of excitotoxicity. This role for ROS signaling challenges the long-held misconception that elevated ROS is only detrimental to cells causing dysfunction and death (<xref ref-type="bibr" rid="bib99">Sies and Jones, 2020</xref>). Instead, mitoROS signaling acts as a physiological signal integrating synaptic function and mitochondrial output to link neuronal connectivity and metabolic capacity. Although additional studies are required to test and refine our working model, it opens the door to many new and impactful questions.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Plasmid construction</title><p>See Appendix 1—key resources table for details on plasmids used in this study. Plasmids were created using In-Fusion Cloning (Takara Bio) or the Gateway recombination (Invitrogen) method. DNA primers were created using Takara Bio’s online In-Fusion Primer Design Tool for In-Fusion Cloning and with the open-source ApE Plasmid Editor (M. Wayne Davis) for the Gateway recombination method.</p></sec><sec id="s4-2"><title><italic>C. elegans</italic> strains</title><p><italic>C. elegans</italic> strains were maintained under standard conditions (<xref ref-type="bibr" rid="bib102">Stiernagle, 2006</xref>) (NGM with OP50 20°C). All animals used in the experiments were 1-day-old adult hermaphrodites that were selected 24 hr prior to the experiments at the L4 stage. Transgenic strains (see Appendix 1—key resources table) were created by microinjection (<xref ref-type="bibr" rid="bib35">Evans, 2006</xref>) of <italic>lin-15(n765ts</italic>) worms with DNA mixes composed of the plasmids described in Appendix 1—key resources table. All DNA mixes included a plasmid containing <italic>lin-15(+</italic>) to allow for phenotypic rescue of transgenic strains (<xref ref-type="bibr" rid="bib85">Praitis and Maduro, 2011</xref>). All strains used in optogenetic experiments were also mutant for the <italic>lite-1</italic> gene (allele: <italic>ok530</italic>) to limit off-target effects of our optical stimulation protocols due to LITE-1 (<xref ref-type="bibr" rid="bib43">Gong et al., 2016</xref>). This protocol for the introduction of recombinant DNA into <italic>C. elegans</italic> has been approved by the National Institutes of Health Institutional Biosafety Committee (protocol no. 18-043B).</p></sec><sec id="s4-3"><title>Confocal microscopy</title><p>All imaging was done using a Yokogawa CSUX1 spinning disc incorporated into a confocal microscope (Olympus IX83) with 405, 488, and 561 nm diode lasers (100–150 mW each; Andor ILE Laser Combiner). Images were captured using an Andor iXon Ultra EMCCD (DU-867) camera and a ×100/1.40NA oil objective (Olympus). Devices were controlled remotely for image acquisition using MetaMorph 7.10.1 (Molecular Devices).</p></sec><sec id="s4-4"><title>In vivo imaging of the AVA neurites</title><p>One-day-old adult hermaphrodites were mounted for imaging by placing a single worm on an agar pad (10% agarose dissolved in M9 buffer) on a microscope slide with 1.6 µL of a solution containing equal measures of polystyrene beads (Polybead, Cat# 00876-15, Polysciences Inc) and 30 mM muscimol (Cat# 195336, MP Biomedicals). Once the muscimol slowed worm movement (~5 min), a coverslip was dropped onto the agar pad, physically restraining the worm. The worm’s orientation was manually adjusted by sliding the coverslip to reorient the positioning of the AVA interneurons for imaging (<xref ref-type="bibr" rid="bib29">Doser et al., 2023</xref>).</p></sec><sec id="s4-5"><title>Whole-cell neuronal stimulation with ChRimson</title><p>Worms from strains expressing ChRimson were picked at the L4s stage onto an NGM/OP50 plate coated with a 100 µM concentration of all-trans-Retinal (Sigma-Aldrich, Cat# R2500-25; diluted with M9 buffer). Worms were left overnight on Retinal plates before optical neuronal activation via an LED array (613 nm, CoolBase 7 LED module from LuxeonStar). ChRimson expression was verified in these strains behaviorally by testing light-induced reversals (data not shown). For ChRimson activation before mito-roGFP imaging, freely behaving 1-day-old adults were placed onto a fresh NGM/OP50 plate 2 inches beneath a 613 nm LED array. LED intensity was adjusted at the beginning of each experiment to 40 µW/mm<sup>2</sup> using a custom potentiometer in combination with a digital optical power console (ThorLabs, PM100C) and photodiode sensor (ThorLabs, S170C). The pattern generator pulsed the LED for 1 s every 30 s (33.3 mHz) for 5–60 min before worms were mounted for imaging.</p></sec><sec id="s4-6"><title>Localized ChRimson activation</title><p>To activate ChRimson within discrete regions of the AVA neurons, the neurites were located using a ×100 objective, the co-expressed fluorescent reagents (i.e., mito-roGFP, GCaMP, or mitoGCaMP), and the 488 nm imaging laser. Briefly, a fluorescent image of the co-expressed reagent in a single Z-plane was acquired and a region mask was created on the AVA neurites. Then, the green LED (with a 605+20 nm filter; Chroma) from an LED illumination system (CoolLED pE300ultra) illuminated the masked region via projection through a Mosaic II digital mirror device (DMD; Andor Mosaic 3) controlled remotely using MetaMorph. LED intensity was adjusted to a total output of 5 µW using a digital optical power console (ThorLabs, PM100C) and microscope slide thermal sensor (ThorLabs, S175C). During the acquisition of an image stream, the master shutter of the DMD was controlled using MetaMorph’s ‘Trigger Components’ function to illuminate the masked region for 3 s every 30 s.</p></sec><sec id="s4-7"><title>Ratiometric fluorescence imaging and analysis of mito-roGFP</title><p>Immediately after ChRimson or mechano-stimulation, worms were mounted for imaging in a 15 mM Muscimol solution. The AVA neurites containing roGFP<sup>+</sup> mitochondria were located, and images were collected with a 500 ms exposure every 0.25 µm to capture a stack of images (5.25 µm) around the neurites. The 525 nm emission was imaged with 405 nm, then 488 nm illumination at each Z-plane. The average roGFP 525 nm fluorescence from 405 or 488 nm excitation was measured at individual mitochondria using MetaMorph’s region measurement tool in a single Z-plane where the roGFP fluorescence due to 488 nm excitation was the highest. The average background fluorescence near each mitochondrion was also collected. The mitochondria region trace was copied to the fluorescence image collected with 405 nm excitation at the corresponding Z-plane, then roGFP and background fluorescence values were logged.</p></sec><sec id="s4-8"><title>Whole-cell mitoKR activation</title><p>Individual 1-day-old adults of transgenic strains (<italic>csfEx168, csfEx195,</italic> or <italic>csfEx188</italic>) containing pRD36 (<italic>Pflp-18::TOMM20::KillerRed::let-858</italic>) as determined by the absence of the multi-vulva phenotype were transferred onto a fresh NGM/OP50 culture plate and placed 2 inches below a 567 nm LED array (CoolBase 7 LED module from LuxeonStar). The light intensity was adjusted to 25 µW/mm<sup>2</sup> with our potentiometer, digital optical power console, and photodiode sensor (S130C). Worms were illuminated for 5 or 10 min before being immediately mounted for imaging.</p></sec><sec id="s4-9"><title>Local mitoKR activation</title><p>For localized photoactivation of mitoKR (TOMM20::KillerRed), the AVA neurites were located using a ×100 objective, the co-expressed fluorescent reagents (i.e., mito-roGFP, GLR-1::GFP, or SEP::GLR-1), and the 488 nm imaging laser. An image of mitoKR fluorescence in a single Z-plane was briefly acquired using a 100 ms exposure time and 561 nm imaging laser. Using this image, a region mask was created around a small region (100–300 µm<sup>2</sup>) containing mitoKR<sup>+</sup> mitochondria. The green LED (with a 590+20 nm filter; Chroma) from our LED illumination system illuminated the masked region via projection of the green light through our DMD controlled using MetaMorph. LED intensity was adjusted to a total output of 10 µW using a digital optical power console (ThorLabs, PM100C) and photodiode sensor (ThorLabs, S130C). By remotely opening the DMD master shuttler, the masked region was illuminated for 15 s.</p></sec><sec id="s4-10"><title>Pharmacological inhibition of MCU-1 with Ru360</title><p>Ru360 (Sigma-Aldrich, Cat# 557440) was reconstituted in water at a concentration of 2 mM, then distributed into 15 µL aliquots (in light safe microcentrifuge tubes) and stored at 4°C. Immediately before treatment an Ru360 aliquot was diluted to 100 µM with M9 buffer. Then, 2–3 animals were placed on an NGM plate with OP50 and 200 µL of 100 µM Ru360 solution was pipetted onto the OP50 lawn where the animals resided, completely covering the lawn. Treatment was applied for 10 min, after which the animal was removed to be used in the outlined imaging protocols. For long-term optogenetic experiments, animals were bathed in the Ru360 treatment for ~10 min before the Ru360-containing media naturally absorbed into the NGM/OP50 plate. The animals remained on this plate while undergoing the optical activation protocol for 5–60 min (see ‘Whole-cell neuronal stimulation with ChRimson’ and ‘Whole-cell mitoKR activation’).</p></sec><sec id="s4-11"><title>Transport imaging and analysis</title><p>All transport imaging was conducted on strains containing <italic>akIs141</italic> in the <italic>glr-1</italic> null background (<italic>ky176</italic>). The AVA neurites were located using the ×100 objective and a 488 nm excitation laser to visualize GFP fluorescence. A consistent Z-plane was held in focus for the entire imaging session using the continuous focus function of a Z drift compensator (Olympus, IX3-ZDC2) controlled remotely using MetaMorph. Then, a proximal section of the neurites was photobleached using a 3 W, 488 nm Coherent solid-state laser (Genesis MX MTM; 0.5 W output; 1 s pulse) directed to the region defined in MetaMorph using a Mosaic II digital mirror device (Andor Mosaic 3). Then, 30 s after photobleaching, an image stream was collected with the 488 nm excitation laser and a 100 ms exposure time. MetaMorph’s Kymograph tool was used to generate kymographs as previously reported (<xref ref-type="bibr" rid="bib53">Hoerndli et al., 2013</xref>). Transport events were quantified by manually counting all transport events from the resultant kymographs. Instantaneous transport velocities were quantified from kymographs using the ImageJ plugin KymoAnalyzer (<xref ref-type="bibr" rid="bib77">Neumann et al., 2017</xref>) as previously described (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>).</p></sec><sec id="s4-12"><title>Fluorescence recovery after photobleaching (FRAP)</title><p>Strains expressing either GLR-1::GFP or SEP::GLR-1 were mounted for imaging as described above. Using the SEP or GFP fluorescence, a proximal region of the AVA neurites was localized. The stage position was memorized using MetaMorph’s stage position memory function and the ideal Z-plane was set using the ZDC control dialogue. An image stack of SEP/GFP fluorescence was then acquired using the 488 nm excitation laser set to a 500 ms exposure. The Z-stack captures the entire width of the AVA process (21 Z-planes; 0.25 µm steps, ± 2.5 µm around the neurite). If photoactivation was required for experiment, the shutter for the CoolLED system (pE-300<sup>ultra</sup>) was opened for the appropriate duration. Then, ~40 µm sections of the neurite proximal and distal to the imaging region were photobleached using the same photobleaching settings as described for GLR-1 transport imaging. Lastly, the imaging region (40–50 µm) was photobleached. Immediately following, an image stack of SEP/GFP fluorescence was acquired for the 0 min timepoint. Subsequent image stacks were acquired every 2 min out to 16 min. The resultant image stacks were processed and analyzed as previously described (<xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>), with the exception of the SEP FRAP dataset in <xref ref-type="fig" rid="fig2">Figure 2C</xref>. The individual timepoints in this dataset were not normalized to the initial fluorescence value per animal because initial SEP::GLR-1 fluorescence was significantly higher in <italic>mcu-1(lf</italic>) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Instead, the 0 min fluorescence values were subtracted from the raw fluorescence values for all subsequent timepoints. Analysis of the fluorescence before photobleaching was analyzed by creating a data file (.log) of fluorescence values along the bleached region of the AVA neurite using MetaMorph’s linescan tool (line width = 20 pixels). The resultant output file was analyzed using a custom MATLAB (R2021a) script to obtain the average area of fluorescent puncta (area under the peak).</p></sec><sec id="s4-13"><title>Imaging of mitoGCaMP and cytoplasmic GCaMP</title><p>The AVA neurite was located and continuous autofocus was set as described above. Image streams (100 ms exposure) were collected with a 488 nm imaging laser (power = 0.1%; attenuation = 10). Localized ChRimson activation (see ‘Localized ChRimson activation’) was triggered every 30 s using MetaMorph’s ‘Trigger Components’ feature starting 30 s after the start of the image stream. Imaging of mitoGCaMP fluorescence was continuous throughout the entire protocol covering all aspects of activation and rest.</p><p>The AVA neurite was located and continuous autofocus set as described above. Then, a 90 s image stream was collected with a 488 nm imaging laser (set to 0.1% power and an attenuation of 10) and a 250 ms exposure. Localized ChRimson activation (see ‘Localized ChRimson activation’) was triggered every 30 s using MetaMorph’s ‘Trigger Components’ feature starting 15 s after the start of the stream acquisition. Imaging of GCaMP6f fluorescence was continuous throughout the optical activation protocol.</p></sec><sec id="s4-14"><title>Experimental design and statistical analyses</title><p>All relevant controls were included for each set of biological replicates and all datasets combine 2–5 replicates conducted on different days. Appropriate sample size for each experiment was based on previously published experiments (<xref ref-type="bibr" rid="bib53">Hoerndli et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Doser et al., 2020</xref>). A post hoc Pearson’s <italic>R</italic> correlation test was conducted for each dataset to ensure a small effect size (|<italic>r</italic>| &lt; 0.3). When manual quantification was required (i.e., for quantification of transport events from kymographs), the dataset was blinded to the genotype and experimental condition. Outliers were removed from datasets using the ROUT method (<italic>Q</italic> = 1%). For FRAP datasets, animals were excluded if 50% or more of the timepoints were considered outliers. Experimental groups were considered significantly different if their comparison using a Student’s <italic>t</italic>-test (for comparing two groups) or one-way ANOVA with correction for multiple comparisons (Dunnett’s or Bonferroni’s; for comparisons &gt;2) yielded a p-value&lt;0.05. To compare the FRAP rate between conditions, we used an extra sum-of-squares <italic>F</italic>-test comparing the best-fit curve for each experimental group with a Bonferroni correction for multiple comparisons. Curves were considered different if a comparison yielded a p-value&lt;0.01.</p></sec><sec id="s4-15"><title>Image and data presentation</title><p>All images were acquired under non-saturating conditions. Representative images were selected as they represent the average. Postprocessing was done following analysis as needed to visualize corresponding quantifications. Images processed for data representation were performed using Photoshop (2023), and all images in each figure panel were identically processed. Graphs were created in GraphPad Prism (9.3.1) and exported as an enhanced metafile for integration into figures that were compiled in Adobe Illustrator (24.3). All data are represented as the mean ± the standard error of the mean. Illustrations were created in their entirety in Adobe Illustrator.</p></sec><sec id="s4-16"><title>Code/software</title><p>Custom Excel modules (created in Excel’s Visual Basic Editor) were used for the analysis of cytoplasmic and mitochondrial calcium imaging. The modules are available online at <ext-link ext-link-type="uri" xlink:href="https://github.com/racheldoser/GCaMP_Analysis_Excel_VBA">https://github.com/racheldoser/GCaMP_Analysis_Excel_VBA</ext-link> (<xref ref-type="bibr" rid="bib27">Doser, 2021</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Validation, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92376-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are accessible on Dryad under the following DOI <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0gb5mkm71">https://doi.org/10.5061/dryad.0gb5mkm71</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Doser</surname><given-names>R</given-names></name><name><surname>Knight</surname><given-names>K</given-names></name><name><surname>Deihl</surname><given-names>E</given-names></name><name><surname>Hoerndli</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Image quantification data for: Activity-dependent mitochondrial ROS signaling regulates recruitment of glutamate receptors to synapses</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.0gb5mkm71</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Sasha de Henau for the mito-roGFP plasmid, Attila Stetak for the GCaMP6f plasmid, and the Caenorhabditis Genetics Center at the University of Minnesota for strains. This work was largely supported in part by an R01 awarded to FJ Hoerndli from NIH/NINDS (NS115947). Additional financial support was provided by the College of Veterinary Medicine and Biomedical Sciences at Colorado State University. <italic>C. elegans</italic> strains were purchased from the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accardi</surname><given-names>MV</given-names></name><name><surname>Daniels</surname><given-names>BA</given-names></name><name><surname>Brown</surname><given-names>P</given-names></name><name><surname>Fritschy</surname><given-names>JM</given-names></name><name><surname>Tyagarajan</surname><given-names>SK</given-names></name><name><surname>Bowie</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial reactive oxygen species regulate the strength of inhibitory GABA-mediated synaptic transmission</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3168</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4168</pub-id><pub-id pub-id-type="pmid">24430741</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>J</given-names></name><name><surname>Alvarez-Illera</surname><given-names>P</given-names></name><name><surname>García-Casas</surname><given-names>P</given-names></name><name><surname>Fonteriz</surname><given-names>RI</given-names></name><name><surname>Montero</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The role of Ca2+ signaling in aging and neurodegeneration: insights from <italic>Caenorhabditis elegans</italic> models</article-title><source>Cells</source><volume>9</volume><elocation-id>204</elocation-id><pub-id pub-id-type="doi">10.3390/cells9010204</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Álvarez-Illera</surname><given-names>P</given-names></name><name><surname>García-Casas</surname><given-names>P</given-names></name><name><surname>Fonteriz</surname><given-names>RI</given-names></name><name><surname>Montero</surname><given-names>M</given-names></name><name><surname>Alvarez</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial Ca2+ dynamics in MCU knockout <italic>C. elegans</italic> worms</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>8622</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21228622</pub-id><pub-id pub-id-type="pmid">33207633</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelova</surname><given-names>PR</given-names></name><name><surname>Abramov</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of mitochondrial ROS in the brain: from physiology to neurodegeneration</article-title><source>FEBS Letters</source><volume>592</volume><fpage>692</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12964</pub-id><pub-id pub-id-type="pmid">29292494</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>DT</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Plasma membrane insertion of the AMPA receptor GluA2 subunit is regulated by NSF binding and Q/R editing of the ion pore</article-title><source>PNAS</source><volume>107</volume><fpage>11080</fpage><lpage>11085</lpage><pub-id pub-id-type="doi">10.1073/pnas.1006584107</pub-id><pub-id pub-id-type="pmid">20534470</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>de Juan-Sanz</surname><given-names>J</given-names></name><name><surname>Farrell</surname><given-names>RJ</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular tuning of the axonal mitochondrial Ca<sup>2+</sup> uniporter ensures metabolic flexibility of neurotransmission</article-title><source>Neuron</source><volume>105</volume><fpage>678</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.11.020</pub-id><pub-id pub-id-type="pmid">31862210</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Back</surname><given-names>P</given-names></name><name><surname>Braeckman</surname><given-names>BP</given-names></name><name><surname>Matthijssens</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ROS in aging <italic>Caenorhabditis elegans</italic>: damage or signaling?</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2012</volume><elocation-id>608478</elocation-id><pub-id pub-id-type="doi">10.1155/2012/608478</pub-id><pub-id pub-id-type="pmid">22966416</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Avshalumov</surname><given-names>MV</given-names></name><name><surname>Patel</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>CR</given-names></name><name><surname>Miller</surname><given-names>EW</given-names></name><name><surname>Chang</surname><given-names>CJ</given-names></name><name><surname>Rice</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>9002</fpage><lpage>9010</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1706-09.2009</pub-id><pub-id pub-id-type="pmid">19605638</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baughman</surname><given-names>JM</given-names></name><name><surname>Perocchi</surname><given-names>F</given-names></name><name><surname>Girgis</surname><given-names>HS</given-names></name><name><surname>Plovanich</surname><given-names>M</given-names></name><name><surname>Belcher-Timme</surname><given-names>CA</given-names></name><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Bao</surname><given-names>XR</given-names></name><name><surname>Strittmatter</surname><given-names>L</given-names></name><name><surname>Goldberger</surname><given-names>O</given-names></name><name><surname>Bogorad</surname><given-names>RL</given-names></name><name><surname>Koteliansky</surname><given-names>V</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter</article-title><source>Nature</source><volume>476</volume><fpage>341</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nature10234</pub-id><pub-id pub-id-type="pmid">21685886</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>KU</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CaM kinase: still Inspiring at 40</article-title><source>Neuron</source><volume>103</volume><fpage>380</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.033</pub-id><pub-id pub-id-type="pmid">31394063</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billups</surname><given-names>B</given-names></name><name><surname>Forsythe</surname><given-names>ID</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>5840</fpage><lpage>5847</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-14-05840.2002</pub-id><pub-id pub-id-type="pmid">12122046</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisbach</surname><given-names>CM</given-names></name><name><surname>Hutto</surname><given-names>RA</given-names></name><name><surname>Poria</surname><given-names>D</given-names></name><name><surname>Cleghorn</surname><given-names>WM</given-names></name><name><surname>Abbas</surname><given-names>F</given-names></name><name><surname>Vinberg</surname><given-names>F</given-names></name><name><surname>Kefalov</surname><given-names>VJ</given-names></name><name><surname>Hurley</surname><given-names>JB</given-names></name><name><surname>Brockerhoff</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial calcium uniporter (MCU) deficiency reveals an alternate path for Ca<sup>2+</sup> uptake in photoreceptor mitochondria</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>16041</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-72708-x</pub-id><pub-id pub-id-type="pmid">32994451</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>K</given-names></name><name><surname>Alexander</surname><given-names>K</given-names></name><name><surname>Francis</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Reactive oxygen sapecies: angels and demons in the life of a neuron</article-title><source>NeuroSci</source><volume>3</volume><fpage>130</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.3390/neurosci3010011</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>MG</given-names></name><name><surname>Johnson</surname><given-names>RC</given-names></name><name><surname>Esteban</surname><given-names>J</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1</article-title><source>Neuron</source><volume>51</volume><fpage>213</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.06.013</pub-id><pub-id pub-id-type="pmid">16846856</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braeckman</surname><given-names>BP</given-names></name><name><surname>Smolders</surname><given-names>A</given-names></name><name><surname>Back</surname><given-names>P</given-names></name><name><surname>De Henau</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo detection of reactive oxygen species and redox Status in <italic>Caenorhabditis elegans</italic></article-title><source>Antioxidants &amp; Redox Signaling</source><volume>25</volume><fpage>577</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1089/ars.2016.6751</pub-id><pub-id pub-id-type="pmid">27306519</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brini</surname><given-names>M</given-names></name><name><surname>Calì</surname><given-names>T</given-names></name><name><surname>Ottolini</surname><given-names>D</given-names></name><name><surname>Carafoli</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intracellular calcium homeostasis and signaling</article-title><source>Metal Ions in Life Sciences</source><volume>12</volume><fpage>119</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-5561-1_5</pub-id><pub-id pub-id-type="pmid">23595672</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MR</given-names></name><name><surname>Sullivan</surname><given-names>PG</given-names></name><name><surname>Geddes</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synaptic mitochondria are more susceptible to Ca2+overload than nonsynaptic mitochondria</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>11658</fpage><lpage>11668</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510303200</pub-id><pub-id pub-id-type="pmid">16517608</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulina</surname><given-names>ME</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Britanova</surname><given-names>OV</given-names></name><name><surname>Yanushevich</surname><given-names>YG</given-names></name><name><surname>Staroverov</surname><given-names>DB</given-names></name><name><surname>Chepurnykh</surname><given-names>TV</given-names></name><name><surname>Merzlyak</surname><given-names>EM</given-names></name><name><surname>Shkrob</surname><given-names>MA</given-names></name><name><surname>Lukyanov</surname><given-names>S</given-names></name><name><surname>Lukyanov</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A genetically encoded photosensitizer</article-title><source>Nature Biotechnology</source><volume>24</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1038/nbt1175</pub-id><pub-id pub-id-type="pmid">16369538</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>BY</given-names></name><name><surname>Byun</surname><given-names>K</given-names></name><name><surname>Cho</surname><given-names>YM</given-names></name><name><surname>Yu</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Hwang</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A systems approach for decoding mitochondrial retrograde signaling pathways</article-title><source>Science Signaling</source><volume>6</volume><elocation-id>rs4</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2003266</pub-id><pub-id pub-id-type="pmid">23443683</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choquet</surname><given-names>D</given-names></name><name><surname>Triller</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The dynamic synapse</article-title><source>Neuron</source><volume>80</volume><fpage>691</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.013</pub-id><pub-id pub-id-type="pmid">24183020</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Citri</surname><given-names>A</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Synaptic plasticity: multiple forms, functions, and mechanisms</article-title><source>Neuropsychopharmacology</source><volume>33</volume><fpage>18</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1301559</pub-id><pub-id pub-id-type="pmid">17728696</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>SJ</given-names></name><name><surname>Jarrell</surname><given-names>TA</given-names></name><name><surname>Brittin</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Bloniarz</surname><given-names>AE</given-names></name><name><surname>Yakovlev</surname><given-names>MA</given-names></name><name><surname>Nguyen</surname><given-names>KCQ</given-names></name><name><surname>Tang</surname><given-names>LTH</given-names></name><name><surname>Bayer</surname><given-names>EA</given-names></name><name><surname>Duerr</surname><given-names>JS</given-names></name><name><surname>Bülow</surname><given-names>HE</given-names></name><name><surname>Hobert</surname><given-names>O</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Emmons</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Whole-animal connectomes of both <italic>Caenorhabditis elegans</italic> sexes</article-title><source>Nature</source><volume>571</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1352-7</pub-id><pub-id pub-id-type="pmid">31270481</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debattisti</surname><given-names>V</given-names></name><name><surname>Gerencser</surname><given-names>AA</given-names></name><name><surname>Saotome</surname><given-names>M</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Hajnóczky</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ros control mitochondrial motility through p38 and the motor adaptor miro/trak</article-title><source>Cell Reports</source><volume>21</volume><fpage>1667</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.060</pub-id><pub-id pub-id-type="pmid">29117569</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devine</surname><given-names>MJ</given-names></name><name><surname>Szulc</surname><given-names>BR</given-names></name><name><surname>Howden</surname><given-names>JH</given-names></name><name><surname>López-Doménech</surname><given-names>G</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Kittler</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mitochondrial Ca2+ uniporter haploinsufficiency enhances long-term potentiation at hippocampal mossy fibre synapses</article-title><source>Journal of Cell Science</source><volume>135</volume><elocation-id>jcs259823</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.259823</pub-id><pub-id pub-id-type="pmid">36274588</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Shanmughapriya</surname><given-names>S</given-names></name><name><surname>Tomar</surname><given-names>D</given-names></name><name><surname>Siddiqui</surname><given-names>N</given-names></name><name><surname>Lynch</surname><given-names>S</given-names></name><name><surname>Nemani</surname><given-names>N</given-names></name><name><surname>Breves</surname><given-names>SL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Palaniappan</surname><given-names>P</given-names></name><name><surname>Riitano</surname><given-names>MF</given-names></name><name><surname>Worth</surname><given-names>AM</given-names></name><name><surname>Seelam</surname><given-names>A</given-names></name><name><surname>Carvalho</surname><given-names>E</given-names></name><name><surname>Subbiah</surname><given-names>R</given-names></name><name><surname>Jaña</surname><given-names>F</given-names></name><name><surname>Soboloff</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>JY</given-names></name><name><surname>Joseph</surname><given-names>SK</given-names></name><name><surname>Caplan</surname><given-names>J</given-names></name><name><surname>Rajan</surname><given-names>S</given-names></name><name><surname>Stathopulos</surname><given-names>PB</given-names></name><name><surname>Madesh</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial Ca<sup>2+</sup> uniporter is a mitochondrial luminal redox sensor that augments MCU channel activity</article-title><source>Molecular Cell</source><volume>65</volume><fpage>1014</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.01.032</pub-id><pub-id pub-id-type="pmid">28262504</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doser</surname><given-names>RL</given-names></name><name><surname>Amberg</surname><given-names>GC</given-names></name><name><surname>Hoerndli</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reactive oxygen species modulate activity-dependent ampa receptor transport in <italic>C. elegans</italic></article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>7405</fpage><lpage>7420</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0902-20.2020</pub-id><pub-id pub-id-type="pmid">32847966</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Doser</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Gcamp_Analysis_Excel_Vba</data-title><version designator="d34f798">d34f798</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/racheldoser/GCaMP_Analysis_Excel_VBA">https://github.com/racheldoser/GCaMP_Analysis_Excel_VBA</ext-link></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doser</surname><given-names>RL</given-names></name><name><surname>Hoerndli</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Decreased reactive oxygen species signaling alters glutamate receptor transport to synapses in <italic>C. elegans</italic> AVA neurons</article-title><source>microPublication Biology</source><volume>01</volume><elocation-id>0528</elocation-id><pub-id pub-id-type="doi">10.17912/micropub.biology.000528</pub-id><pub-id pub-id-type="pmid">35622512</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doser</surname><given-names>R</given-names></name><name><surname>Knight</surname><given-names>KM</given-names></name><name><surname>Deihl</surname><given-names>E</given-names></name><name><surname>Hoerndli</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Subcellular imaging of neuronal calcium handling in vivo</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>4928</elocation-id><pub-id pub-id-type="doi">10.3791/64928</pub-id><pub-id pub-id-type="pmid">37010315</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drum</surname><given-names>BML</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wordeman</surname><given-names>L</given-names></name><name><surname>Santana</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oxidative stress decreases microtubule growth and stability in ventricular myocytes</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>93</volume><fpage>32</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.02.012</pub-id><pub-id pub-id-type="pmid">26902968</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duchen</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mitochondria and calcium: from cell signalling to cell death</article-title><source>The Journal of Physiology</source><volume>529 Pt 1</volume><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00057.x</pub-id><pub-id pub-id-type="pmid">11080251</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting</article-title><source>Neuron</source><volume>28</volume><fpage>511</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)00129-x</pub-id><pub-id pub-id-type="pmid">11144360</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>JR</given-names></name><name><surname>Joiner</surname><given-names>MA</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Kutschke</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Oddis</surname><given-names>CV</given-names></name><name><surname>Bartlett</surname><given-names>RK</given-names></name><name><surname>Lowe</surname><given-names>JS</given-names></name><name><surname>O’Donnell</surname><given-names>SE</given-names></name><name><surname>Aykin-Burns</surname><given-names>N</given-names></name><name><surname>Zimmerman</surname><given-names>MC</given-names></name><name><surname>Zimmerman</surname><given-names>K</given-names></name><name><surname>Ham</surname><given-names>AJL</given-names></name><name><surname>Weiss</surname><given-names>RM</given-names></name><name><surname>Spitz</surname><given-names>DR</given-names></name><name><surname>Shea</surname><given-names>MA</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation</article-title><source>Cell</source><volume>133</volume><fpage>462</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.02.048</pub-id><pub-id pub-id-type="pmid">18455987</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteves da Silva</surname><given-names>M</given-names></name><name><surname>Adrian</surname><given-names>M</given-names></name><name><surname>Schätzle</surname><given-names>P</given-names></name><name><surname>Lipka</surname><given-names>J</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Futai</surname><given-names>K</given-names></name><name><surname>Wierenga</surname><given-names>CJ</given-names></name><name><surname>Kapitein</surname><given-names>LC</given-names></name><name><surname>Hoogenraad</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Positioning of ampa receptor-containing endosomes regulates synapse architecture</article-title><source>Cell Reports</source><volume>13</volume><fpage>933</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.062</pub-id><pub-id pub-id-type="pmid">26565907</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Transformation and microinjection</article-title><source>WormBook</source><volume>01</volume><elocation-id>108.1</elocation-id><pub-id pub-id-type="doi">10.1895/wormbook.1.108.1</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Bourdette</surname><given-names>D</given-names></name><name><surname>Banker</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases</article-title><source>Molecular Neurodegeneration</source><volume>7</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1326-7-29</pub-id><pub-id pub-id-type="pmid">22709375</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria-Pereira</surname><given-names>A</given-names></name><name><surname>Morais</surname><given-names>VA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Synapses: the brain’s energy-demanding sites</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>3627</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23073627</pub-id><pub-id pub-id-type="pmid">35408993</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiuza</surname><given-names>M</given-names></name><name><surname>Rostosky</surname><given-names>CM</given-names></name><name><surname>Parkinson</surname><given-names>GT</given-names></name><name><surname>Bygrave</surname><given-names>AM</given-names></name><name><surname>Halemani</surname><given-names>N</given-names></name><name><surname>Baptista</surname><given-names>M</given-names></name><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Hanley</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PICK1 regulates AMPA receptor endocytosis via direct interactions with AP2 α-appendage and dynamin</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>3323</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.1083/jcb.201701034</pub-id><pub-id pub-id-type="pmid">28855251</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>DW</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name><name><surname>Yao</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondria in hippocampal presynaptic and postsynaptic compartments differ in size as well as intensity</article-title><source>Matters</source><volume>01</volume><elocation-id>0009</elocation-id><pub-id pub-id-type="doi">10.19185/matters.201711000009</pub-id><pub-id pub-id-type="pmid">31058178</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>Marchi</surname><given-names>S</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The machineries, regulation and cellular functions of mitochondrial calcium</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>19</volume><fpage>713</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0052-8</pub-id><pub-id pub-id-type="pmid">30143745</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>YM</given-names></name><name><surname>Jones</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The redox proteome</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>26512</fpage><lpage>26520</lpage><pub-id pub-id-type="doi">10.1074/jbc.R113.464131</pub-id><pub-id pub-id-type="pmid">23861437</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldblum</surname><given-names>RR</given-names></name><name><surname>McClellan</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>K</given-names></name><name><surname>Gonzalez</surname><given-names>SJ</given-names></name><name><surname>Thompson</surname><given-names>BR</given-names></name><name><surname>Vang</surname><given-names>HX</given-names></name><name><surname>Cohen</surname><given-names>H</given-names></name><name><surname>Higgins</surname><given-names>L</given-names></name><name><surname>Markowski</surname><given-names>TW</given-names></name><name><surname>Yang</surname><given-names>TY</given-names></name><name><surname>Metzger</surname><given-names>JM</given-names></name><name><surname>Gardner</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Oxidative stress pathogenically remodels the cardiac myocyte cytoskeleton via structural alterations to the microtubule lattice</article-title><source>Developmental Cell</source><volume>56</volume><fpage>2252</fpage><lpage>2266</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.07.004</pub-id><pub-id pub-id-type="pmid">34343476</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Ward</surname><given-names>A</given-names></name><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>XZS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The <italic>C. elegans</italic> taste receptor homolog LITE-1 Is a photoreceptor</article-title><source>Cell</source><volume>167</volume><fpage>1252</fpage><lpage>1263</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.053</pub-id><pub-id pub-id-type="pmid">27863243</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Görlach</surname><given-names>A</given-names></name><name><surname>Bertram</surname><given-names>K</given-names></name><name><surname>Hudecova</surname><given-names>S</given-names></name><name><surname>Krizanova</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Calcium and ROS: a mutual interplay</article-title><source>Redox Biology</source><volume>6</volume><fpage>260</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.08.010</pub-id><pub-id pub-id-type="pmid">26296072</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>LC</given-names></name><name><surname>Eaton</surname><given-names>SL</given-names></name><name><surname>Brunton</surname><given-names>PJ</given-names></name><name><surname>Atrih</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Lamont</surname><given-names>DJ</given-names></name><name><surname>Gillingwater</surname><given-names>TH</given-names></name><name><surname>Pennetta</surname><given-names>G</given-names></name><name><surname>Skehel</surname><given-names>P</given-names></name><name><surname>Wishart</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture</article-title><source>Molecular Neurodegeneration</source><volume>12</volume><elocation-id>77</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-017-0221-9</pub-id><pub-id pub-id-type="pmid">29078798</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groten</surname><given-names>CJ</given-names></name><name><surname>MacVicar</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mitochondrial Ca<sup>2+</sup> uptake by the MCU facilitates pyramidal neuron excitability and metabolism during action potential firing</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>900</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-03848-1</pub-id><pub-id pub-id-type="pmid">36056095</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutiérrez</surname><given-names>Y</given-names></name><name><surname>López-García</surname><given-names>S</given-names></name><name><surname>Lario</surname><given-names>A</given-names></name><name><surname>Gutiérrez-Eisman</surname><given-names>S</given-names></name><name><surname>Delevoye</surname><given-names>C</given-names></name><name><surname>Esteban</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>KIF13A drives AMPA receptor synaptic delivery for long-term potentiation via endosomal remodeling</article-title><source>The Journal of Cell Biology</source><volume>220</volume><elocation-id>e202003183</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.202003183</pub-id><pub-id pub-id-type="pmid">33999113</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>J</given-names></name><name><surname>Brustovetsky</surname><given-names>T</given-names></name><name><surname>Rysted</surname><given-names>JE</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Usachev</surname><given-names>YM</given-names></name><name><surname>Brustovetsky</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake and induction of the permeability transition pore in brain mitochondria</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>15652</fpage><lpage>15663</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.002926</pub-id><pub-id pub-id-type="pmid">30154242</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hangen</surname><given-names>E</given-names></name><name><surname>Cordelières</surname><given-names>FP</given-names></name><name><surname>Petersen</surname><given-names>JD</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name><name><surname>Coussen</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuronal activity and intracellular calcium levels regulate intracellular transport of newly synthesized ampar</article-title><source>Cell Reports</source><volume>24</volume><fpage>1001</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.095</pub-id><pub-id pub-id-type="pmid">30044968</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>NSF binds calcium to regulate its interaction with AMPA receptor subunit GluR2</article-title><source>Journal of Neurochemistry</source><volume>101</volume><fpage>1644</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04455.x</pub-id><pub-id pub-id-type="pmid">17302911</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidalgo</surname><given-names>C</given-names></name><name><surname>Arias-Cavieres</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Calcium, reactive oxygen species, and synaptic plasticity</article-title><source>Physiology</source><volume>31</volume><fpage>201</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1152/physiol.00038.2015</pub-id><pub-id pub-id-type="pmid">27053734</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Kwon</surname><given-names>SK</given-names></name><name><surname>Paek</surname><given-names>H</given-names></name><name><surname>Pernice</surname><given-names>WM</given-names></name><name><surname>Paul</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Erfani</surname><given-names>P</given-names></name><name><surname>Raczkowski</surname><given-names>A</given-names></name><name><surname>Petrey</surname><given-names>DS</given-names></name><name><surname>Pon</surname><given-names>LA</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ER-mitochondria tethering by PDZD8 regulates Ca<sup>2+</sup> dynamics in mammalian neurons</article-title><source>Science</source><volume>358</volume><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1126/science.aan6009</pub-id><pub-id pub-id-type="pmid">29097544</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoerndli</surname><given-names>FJ</given-names></name><name><surname>Maxfield</surname><given-names>DA</given-names></name><name><surname>Brockie</surname><given-names>PJ</given-names></name><name><surname>Mellem</surname><given-names>JE</given-names></name><name><surname>Jensen</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Madsen</surname><given-names>DM</given-names></name><name><surname>Maricq</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Kinesin-1 regulates synaptic strength by mediating the delivery, removal, and redistribution of AMPA receptors</article-title><source>Neuron</source><volume>80</volume><fpage>1421</fpage><lpage>1437</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.050</pub-id><pub-id pub-id-type="pmid">24360545</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoerndli</surname><given-names>FJ</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Mellem</surname><given-names>JE</given-names></name><name><surname>Kallarackal</surname><given-names>A</given-names></name><name><surname>Brockie</surname><given-names>PJ</given-names></name><name><surname>Thacker</surname><given-names>C</given-names></name><name><surname>Madsen</surname><given-names>DM</given-names></name><name><surname>Maricq</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neuronal activity and camkii regulate kinesin-mediated transport of synaptic ampars</article-title><source>Neuron</source><volume>86</volume><fpage>457</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.011</pub-id><pub-id pub-id-type="pmid">25843407</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoerndli</surname><given-names>FJ</given-names></name><name><surname>Brockie</surname><given-names>PJ</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Mellem</surname><given-names>JE</given-names></name><name><surname>Kallarackal</surname><given-names>A</given-names></name><name><surname>Doser</surname><given-names>RL</given-names></name><name><surname>Pierce</surname><given-names>DM</given-names></name><name><surname>Madsen</surname><given-names>DM</given-names></name><name><surname>Maricq</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>MAPK signaling and a mobile scaffold complex regulate AMPA receptor transport to modulate synaptic strength</article-title><source>Cell Reports</source><volume>38</volume><elocation-id>110577</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110577</pub-id><pub-id pub-id-type="pmid">35354038</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huddleston</surname><given-names>AT</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Takeshima</surname><given-names>H</given-names></name><name><surname>Hamilton</surname><given-names>SL</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Superoxide-induced potentiation in the hippocampus requires activation of ryanodine receptor type 3 and ERK</article-title><source>Journal of Neurophysiology</source><volume>99</volume><fpage>1565</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.1152/jn.00659.2007</pub-id><pub-id pub-id-type="pmid">18199822</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>AMPARs and synaptic plasticity: the last 25 years</article-title><source>Neuron</source><volume>80</volume><fpage>704</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.025</pub-id><pub-id pub-id-type="pmid">24183021</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Q</given-names></name><name><surname>Sieburth</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mitochondrial hydrogen peroxide positively regulates neuropeptide secretion during diet-induced activation of the oxidative stress response</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2304</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22561-x</pub-id><pub-id pub-id-type="pmid">33863916</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Lisman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A labile component of AMPA receptor-mediated synaptic transmission is dependent on microtubule motors, actin, and N-ethylmaleimide-sensitive factor</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>4188</fpage><lpage>4194</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-12-04188.2001</pub-id><pub-id pub-id-type="pmid">11404404</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name><name><surname>Chung</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial Ca(2+) uptake is essential for synaptic plasticity in pain</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>12982</fpage><lpage>12991</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3093-11.2011</pub-id><pub-id pub-id-type="pmid">21900577</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klann</surname><given-names>E</given-names></name><name><surname>Roberson</surname><given-names>ED</given-names></name><name><surname>Knapp</surname><given-names>LT</given-names></name><name><surname>Sweatt</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A role for superoxide in protein kinase C activation and induction of long-term potentiation</article-title><source>The Journal of Biological Chemistry</source><volume>273</volume><fpage>4516</fpage><lpage>4522</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.8.4516</pub-id><pub-id pub-id-type="pmid">9468506</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klapoetke</surname><given-names>NC</given-names></name><name><surname>Murata</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Pulver</surname><given-names>SR</given-names></name><name><surname>Birdsey-Benson</surname><given-names>A</given-names></name><name><surname>Cho</surname><given-names>YK</given-names></name><name><surname>Morimoto</surname><given-names>TK</given-names></name><name><surname>Chuong</surname><given-names>AS</given-names></name><name><surname>Carpenter</surname><given-names>EJ</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chow</surname><given-names>BY</given-names></name><name><surname>Surek</surname><given-names>B</given-names></name><name><surname>Melkonian</surname><given-names>M</given-names></name><name><surname>Jayaraman</surname><given-names>V</given-names></name><name><surname>Constantine-Paton</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>GKS</given-names></name><name><surname>Boyden</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Independent optical excitation of distinct neural populations</article-title><source>Nature Methods</source><volume>11</volume><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2836</pub-id><pub-id pub-id-type="pmid">24509633</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>LT</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>674</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-03-00674.2002</pub-id><pub-id pub-id-type="pmid">11826097</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinidis</surname><given-names>K</given-names></name><name><surname>Bezzerides</surname><given-names>VJ</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><name><surname>Isbell</surname><given-names>HM</given-names></name><name><surname>Wei</surname><given-names>AC</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Viswanathan</surname><given-names>MC</given-names></name><name><surname>Blum</surname><given-names>ID</given-names></name><name><surname>Granger</surname><given-names>JM</given-names></name><name><surname>Heims-Waldron</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Luczak</surname><given-names>ED</given-names></name><name><surname>Murphy</surname><given-names>KR</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Gratz</surname><given-names>DH</given-names></name><name><surname>Manta</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Kolodkin</surname><given-names>AL</given-names></name><name><surname>Gladyshev</surname><given-names>VN</given-names></name><name><surname>Hund</surname><given-names>TJ</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name><name><surname>Wu</surname><given-names>MN</given-names></name><name><surname>Cammarato</surname><given-names>A</given-names></name><name><surname>Bianchet</surname><given-names>MA</given-names></name><name><surname>Shea</surname><given-names>MA</given-names></name><name><surname>Levine</surname><given-names>RL</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII</article-title><source>The Journal of Clinical Investigation</source><volume>130</volume><fpage>4663</fpage><lpage>4678</lpage><pub-id pub-id-type="doi">10.1172/JCI133181</pub-id><pub-id pub-id-type="pmid">32749237</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Ho</surname><given-names>WK</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Target cell-specific involvement of presynaptic mitochondria in post-tetanic potentiation at hippocampal mossy fiber synapses</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>13603</fpage><lpage>13613</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3985-07.2007</pub-id><pub-id pub-id-type="pmid">18077672</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DZ</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name><name><surname>Chung</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Reactive oxygen species (ROS) modulate AMPA receptor phosphorylation and cell-surface localization in concert with pain-related behavior</article-title><source>Pain</source><volume>153</volume><fpage>1905</fpage><lpage>1915</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2012.06.001</pub-id><pub-id pub-id-type="pmid">22770842</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Kwon</surname><given-names>SK</given-names></name><name><surname>Lewis</surname><given-names>TL</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Emerging roles of mitochondria in synaptic transmission and neurodegeneration</article-title><source>Current Opinion in Physiology</source><volume>3</volume><fpage>82</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.cophys.2018.03.009</pub-id><pub-id pub-id-type="pmid">30320242</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JB</given-names></name><name><surname>Huang</surname><given-names>BK</given-names></name><name><surname>Deen</surname><given-names>WM</given-names></name><name><surname>Sikes</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Analysis of the lifetime and spatial localization of hydrogen peroxide generated in the cytosol using a reduced kinetic model</article-title><source>Free Radical Biology &amp; Medicine</source><volume>89</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.07.009</pub-id><pub-id pub-id-type="pmid">26169725</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maricq</surname><given-names>AV</given-names></name><name><surname>Peckol</surname><given-names>E</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Bargmann</surname><given-names>CI</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Mechanosensory signalling in <italic>C. elegans</italic> mediated by the GLR-1 glutamate receptor</article-title><source>Nature</source><volume>378</volume><fpage>78</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/378078a0</pub-id><pub-id pub-id-type="pmid">7477293</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Márkus</surname><given-names>NM</given-names></name><name><surname>Hasel</surname><given-names>P</given-names></name><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Bell</surname><given-names>KFS</given-names></name><name><surname>Heron</surname><given-names>S</given-names></name><name><surname>Kind</surname><given-names>PC</given-names></name><name><surname>Dando</surname><given-names>O</given-names></name><name><surname>Simpson</surname><given-names>TI</given-names></name><name><surname>Hardingham</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Expression of mrna encoding mcu and other mitochondrial calcium regulatory genes depends on cell type, neuronal subtype, and ca2+ signaling</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0148164</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0148164</pub-id><pub-id pub-id-type="pmid">26828201</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marland</surname><given-names>JRK</given-names></name><name><surname>Hasel</surname><given-names>P</given-names></name><name><surname>Bonnycastle</surname><given-names>K</given-names></name><name><surname>Cousin</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondrial calcium uptake modulates synaptic vesicle endocytosis in central nerve terminals</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>2080</fpage><lpage>2086</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.686956</pub-id><pub-id pub-id-type="pmid">26644474</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massaad</surname><given-names>CA</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Reactive oxygen species in the regulation of synaptic plasticity and memory</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>14</volume><fpage>2013</fpage><lpage>2054</lpage><pub-id pub-id-type="doi">10.1089/ars.2010.3208</pub-id><pub-id pub-id-type="pmid">20649473</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miseta</surname><given-names>A</given-names></name><name><surname>Csutora</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Relationship between the occurrence of cysteine in proteins and the complexity of organisms</article-title><source>Molecular Biology and Evolution</source><volume>17</volume><fpage>1232</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a026406</pub-id><pub-id pub-id-type="pmid">10908643</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>B</given-names></name><name><surname>Sobotta</surname><given-names>MC</given-names></name><name><surname>Dick</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Measuring E(GSH) and H2O2 with roGFP2-based redox probes</article-title><source>Free Radical Biology &amp; Medicine</source><volume>51</volume><fpage>1943</fpage><lpage>1951</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.08.035</pub-id><pub-id pub-id-type="pmid">21964034</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morsci</surname><given-names>NS</given-names></name><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Age-related phasic patterns of mitochondrial maintenance in adult <italic>Caenorhabditis elegans</italic> neurons</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>1373</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2799-15.2016</pub-id><pub-id pub-id-type="pmid">26818523</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahata</surname><given-names>Y</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Plasticity of spine structure: local signaling, translation and cytoskeletal reorganization</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>10</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2018.00029</pub-id><pub-id pub-id-type="pmid">30210329</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>S</given-names></name><name><surname>Chassefeyre</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>GE</given-names></name><name><surname>Encalada</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>KymoAnalyzer: a software tool for the quantitative analysis of intracellular transport in neurons</article-title><source>Traffic</source><volume>18</volume><fpage>71</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1111/tra.12456</pub-id><pub-id pub-id-type="pmid">27770501</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>M</given-names></name><name><surname>Elustondo</surname><given-names>PA</given-names></name><name><surname>Warford</surname><given-names>J</given-names></name><name><surname>Thirumaran</surname><given-names>A</given-names></name><name><surname>Pavlov</surname><given-names>EV</given-names></name><name><surname>Robertson</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Global ablation of the mitochondrial calcium uniporter increases glycolysis in cortical neurons subjected to energetic stressors</article-title><source>Journal of Cerebral Blood Flow and Metabolism</source><volume>37</volume><fpage>3027</fpage><lpage>3041</lpage><pub-id pub-id-type="doi">10.1177/0271678X16682250</pub-id><pub-id pub-id-type="pmid">27909264</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemeyer</surname><given-names>J</given-names></name><name><surname>Scheuring</surname><given-names>D</given-names></name><name><surname>Oestreicher</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>B</given-names></name><name><surname>Schroda</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Real-time monitoring of subcellular H2O2 distribution in <italic>Chlamydomonas reinhardtii</italic></article-title><source>The Plant Cell</source><volume>33</volume><fpage>2935</fpage><lpage>2949</lpage><pub-id pub-id-type="doi">10.1093/plcell/koab176</pub-id><pub-id pub-id-type="pmid">34196712</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Hare</surname><given-names>JK</given-names></name><name><surname>Gonzalez</surname><given-names>KC</given-names></name><name><surname>Herrlinger</surname><given-names>SA</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Hewitt</surname><given-names>VL</given-names></name><name><surname>Blockus</surname><given-names>H</given-names></name><name><surname>Szoboszlay</surname><given-names>M</given-names></name><name><surname>Rolotti</surname><given-names>SV</given-names></name><name><surname>Geiller</surname><given-names>TC</given-names></name><name><surname>Negrean</surname><given-names>A</given-names></name><name><surname>Chelur</surname><given-names>V</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name><name><surname>Losonczy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Compartment-specific tuning of dendritic feature selectivity by intracellular Ca<sup>2+</sup> release</article-title><source>Science</source><volume>375</volume><elocation-id>eabm1670</elocation-id><pub-id pub-id-type="doi">10.1126/science.abm1670</pub-id><pub-id pub-id-type="pmid">35298275</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oswald</surname><given-names>MC</given-names></name><name><surname>Brooks</surname><given-names>PS</given-names></name><name><surname>Zwart</surname><given-names>MF</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>RJ</given-names></name><name><surname>Giachello</surname><given-names>CN</given-names></name><name><surname>Morarach</surname><given-names>K</given-names></name><name><surname>Baines</surname><given-names>RA</given-names></name><name><surname>Sweeney</surname><given-names>ST</given-names></name><name><surname>Landgraf</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Reactive oxygen species regulate activity-dependent neuronal plasticity in <italic>Drosophila</italic></article-title><source>eLife</source><volume>7</volume><elocation-id>e39393</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39393</pub-id><pub-id pub-id-type="pmid">30540251</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oswald</surname><given-names>MCW</given-names></name><name><surname>Garnham</surname><given-names>N</given-names></name><name><surname>Sweeney</surname><given-names>ST</given-names></name><name><surname>Landgraf</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>Regulation of neuronal development and function by ROS</article-title><source>FEBS Letters</source><volume>592</volume><fpage>679</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12972</pub-id><pub-id pub-id-type="pmid">29323696</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrini</surname><given-names>EM</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Cognet</surname><given-names>L</given-names></name><name><surname>Lounis</surname><given-names>B</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Endocytic trafficking and recycling maintain a pool of mobile surface AMPA receptors required for synaptic potentiation</article-title><source>Neuron</source><volume>63</volume><fpage>92</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2009.05.025</pub-id><pub-id pub-id-type="pmid">19607795</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petriv</surname><given-names>OI</given-names></name><name><surname>Rachubinski</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Lack of peroxisomal catalase causes a progeric phenotype in <italic>Caenorhabditis elegans</italic></article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>19996</fpage><lpage>20001</lpage><pub-id pub-id-type="doi">10.1074/jbc.M400207200</pub-id><pub-id pub-id-type="pmid">14996832</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Praitis</surname><given-names>V</given-names></name><name><surname>Maduro</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2011">2011</year><chapter-title>Transgenesis in C Elegans</chapter-title><person-group person-group-type="editor"><name><surname>Rothman</surname><given-names>JH</given-names></name><name><surname>Singson</surname><given-names>A</given-names></name></person-group><source>Methods in Cell Biology</source><publisher-name>Elsevier</publisher-name><fpage>159</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-544172-8.00006-2</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>SQ</given-names></name><name><surname>Yan</surname><given-names>JZ</given-names></name><name><surname>Zhang</surname><given-names>XY</given-names></name><name><surname>Bu</surname><given-names>YF</given-names></name><name><surname>Pan</surname><given-names>WW</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PKCλ is critical in AMPA receptor phosphorylation and synaptic incorporation during LTP</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>1365</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.60</pub-id><pub-id pub-id-type="pmid">23511975</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzuto</surname><given-names>R</given-names></name><name><surname>De Stefani</surname><given-names>D</given-names></name><name><surname>Raffaello</surname><given-names>A</given-names></name><name><surname>Mammucari</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitochondria as sensors and regulators of calcium signalling</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>566</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1038/nrm3412</pub-id><pub-id pub-id-type="pmid">22850819</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robison</surname><given-names>AJ</given-names></name><name><surname>Winder</surname><given-names>DG</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name><name><surname>Bartlett</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Oxidation of calmodulin alters activation and regulation of CaMKII</article-title><source>Biochemical and Biophysical Research Communications</source><volume>356</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.02.087</pub-id><pub-id pub-id-type="pmid">17343827</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rongo</surname><given-names>C</given-names></name><name><surname>Kaplan</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>CaMKII regulates the density of central glutamatergic synapses in vivo</article-title><source>Nature</source><volume>402</volume><fpage>195</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1038/46065</pub-id><pub-id pub-id-type="pmid">10647013</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Pizzo</surname><given-names>P</given-names></name><name><surname>Filadi</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Calcium, mitochondria and cell metabolism: a functional triangle in bioenergetics</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1866</volume><fpage>1068</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2018.10.016</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>WR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanosensory molecules and circuits in <italic>C. elegans</italic></article-title><source>Pflugers Archiv</source><volume>467</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s00424-014-1574-3</pub-id><pub-id pub-id-type="pmid">25053538</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnitzer</surname><given-names>MJ</given-names></name><name><surname>Block</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Kinesin hydrolyses one ATP per 8-nm step</article-title><source>Nature</source><volume>388</volume><fpage>386</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1038/41111</pub-id><pub-id pub-id-type="pmid">9237757</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnitzer</surname><given-names>MJ</given-names></name><name><surname>Visscher</surname><given-names>K</given-names></name><name><surname>Block</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Force production by single kinesin motors</article-title><source>Nature Cell Biology</source><volume>2</volume><fpage>718</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1038/35036345</pub-id><pub-id pub-id-type="pmid">11025662</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>P</given-names></name><name><surname>Samuel</surname><given-names>ADT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Caenorhabditis elegans</italic>: a model system for systems neuroscience</article-title><source>Current Opinion in Neurobiology</source><volume>19</volume><fpage>637</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2009.09.009</pub-id><pub-id pub-id-type="pmid">19896359</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setou</surname><given-names>M</given-names></name><name><surname>Seog</surname><given-names>DH</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Takei</surname><given-names>Y</given-names></name><name><surname>Kawagishi</surname><given-names>M</given-names></name><name><surname>Hirokawa</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites</article-title><source>Nature</source><volume>417</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1038/nature743</pub-id><pub-id pub-id-type="pmid">11986669</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial trafficking and anchoring in neurons: new insight and implications</article-title><source>The Journal of Cell Biology</source><volume>204</volume><fpage>1087</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1083/jcb.201312123</pub-id><pub-id pub-id-type="pmid">24687278</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Redox-regulated lipid membrane binding of the PICK1 PDZ domain</article-title><source>Biochemistry</source><volume>49</volume><fpage>4432</fpage><lpage>4439</lpage><pub-id pub-id-type="doi">10.1021/bi100269t</pub-id><pub-id pub-id-type="pmid">20426484</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress</article-title><source>Redox Biology</source><volume>11</volume><fpage>613</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2016.12.035</pub-id><pub-id pub-id-type="pmid">28110218</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>21</volume><fpage>363</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0230-3</pub-id><pub-id pub-id-type="pmid">32231263</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stauch</surname><given-names>KL</given-names></name><name><surname>Purnell</surname><given-names>PR</given-names></name><name><surname>Fox</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantitative proteomics of synaptic and nonsynaptic mitochondria: insights for synaptic mitochondrial vulnerability</article-title><source>Journal of Proteome Research</source><volume>13</volume><fpage>2620</fpage><lpage>2636</lpage><pub-id pub-id-type="doi">10.1021/pr500295n</pub-id><pub-id pub-id-type="pmid">24708184</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanisms for redox-regulation of protein kinase C</article-title><source>Frontiers in Pharmacology</source><volume>6</volume><elocation-id>128</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2015.00128</pub-id><pub-id pub-id-type="pmid">26157389</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="book"><person-group person-group-type="author"><collab>Stiernagle</collab></person-group><year iso-8601-date="2006">2006</year><source>Maintenance of C. elegans</source><publisher-name>WormBook</publisher-name><pub-id pub-id-type="doi">10.1895/wormbook.1.101.1</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoler</surname><given-names>O</given-names></name><name><surname>Stavsky</surname><given-names>A</given-names></name><name><surname>Khrapunsky</surname><given-names>Y</given-names></name><name><surname>Melamed</surname><given-names>I</given-names></name><name><surname>Stutzmann</surname><given-names>G</given-names></name><name><surname>Gitler</surname><given-names>D</given-names></name><name><surname>Sekler</surname><given-names>I</given-names></name><name><surname>Fleidervish</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Frequency- and spike-timing-dependent mitochondrial Ca<sup>2+</sup> signaling regulates the metabolic rate and synaptic efficacy in cortical neurons</article-title><source>eLife</source><volume>11</volume><elocation-id>e74606</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.74606</pub-id><pub-id pub-id-type="pmid">35192454</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Qiao</surname><given-names>H</given-names></name><name><surname>Pan</surname><given-names>PY</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Motile axonal mitochondria contribute to the variability of presynaptic strength</article-title><source>Cell Reports</source><volume>4</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.040</pub-id><pub-id pub-id-type="pmid">23891000</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SR</given-names></name><name><surname>Santpere</surname><given-names>G</given-names></name><name><surname>Weinreb</surname><given-names>A</given-names></name><name><surname>Barrett</surname><given-names>A</given-names></name><name><surname>Reilly</surname><given-names>MB</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Varol</surname><given-names>E</given-names></name><name><surname>Oikonomou</surname><given-names>P</given-names></name><name><surname>Glenwinkel</surname><given-names>L</given-names></name><name><surname>McWhirter</surname><given-names>R</given-names></name><name><surname>Poff</surname><given-names>A</given-names></name><name><surname>Basavaraju</surname><given-names>M</given-names></name><name><surname>Rafi</surname><given-names>I</given-names></name><name><surname>Yemini</surname><given-names>E</given-names></name><name><surname>Cook</surname><given-names>SJ</given-names></name><name><surname>Abrams</surname><given-names>A</given-names></name><name><surname>Vidal</surname><given-names>B</given-names></name><name><surname>Cros</surname><given-names>C</given-names></name><name><surname>Tavazoie</surname><given-names>S</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>Hammarlund</surname><given-names>M</given-names></name><name><surname>Hobert</surname><given-names>O</given-names></name><name><surname>Miller</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular topography of an entire nervous system</article-title><source>Cell</source><volume>184</volume><fpage>4329</fpage><lpage>4347</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.06.023</pub-id><pub-id pub-id-type="pmid">34237253</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Gutiérrez</surname><given-names>C</given-names></name><name><surname>Jiménez-Blasco</surname><given-names>D</given-names></name><name><surname>Quintana-Cabrera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Intertwined ros and metabolic signaling at the neuron-astrocyte interface</article-title><source>Neurochemical Research</source><volume>46</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1007/s11064-020-02965-9</pub-id><pub-id pub-id-type="pmid">31989468</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wacquier</surname><given-names>B</given-names></name><name><surname>Combettes</surname><given-names>L</given-names></name><name><surname>Dupont</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cytoplasmic and mitochondrial calcium signaling: a two-way relationship</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>11</volume><elocation-id>a035139</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a035139</pub-id><pub-id pub-id-type="pmid">31110132</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YN</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Zhang</surname><given-names>YW</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Protein interacting with C-Kinase 1 deficiency impairs glutathione synthesis and increases oxidative stress via reduction of surface excitatory amino acid carrier 1</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>6429</fpage><lpage>6443</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3966-14.2015</pub-id><pub-id pub-id-type="pmid">25904794</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widagdo</surname><given-names>J</given-names></name><name><surname>Guntupalli</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>SE</given-names></name><name><surname>Anggono</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of AMPA receptor trafficking by protein ubiquitination</article-title><source>Frontiers in Molecular Neuroscience</source><volume>10</volume><elocation-id>347</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2017.00347</pub-id><pub-id pub-id-type="pmid">29123470</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>González-Billault</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking</article-title><source>Frontiers in Cellular Neuroscience</source><volume>9</volume><elocation-id>381</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2015.00381</pub-id><pub-id pub-id-type="pmid">26483635</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>JJ</given-names></name><name><surname>Nemani</surname><given-names>N</given-names></name><name><surname>Shanmughapriya</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Nathan</surname><given-names>SR</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Carvalho</surname><given-names>E</given-names></name><name><surname>Ramachandran</surname><given-names>K</given-names></name><name><surname>Srikantan</surname><given-names>S</given-names></name><name><surname>Stathopulos</surname><given-names>PB</given-names></name><name><surname>Wilson</surname><given-names>JJ</given-names></name><name><surname>Madesh</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A selective and cell-permeable mitochondrial calcium uniporter (mcu) inhibitor preserves mitochondrial bioenergetics after hypoxia/reoxygenation injury</article-title><source>ACS Central Science</source><volume>5</volume><fpage>153</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.8b00773</pub-id><pub-id pub-id-type="pmid">30693334</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chisholm</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>C. elegans</italic> epidermal wounding induces a mitochondrial ROS burst that promotes wound repair</article-title><source>Developmental Cell</source><volume>31</volume><fpage>48</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.08.002</pub-id><pub-id pub-id-type="pmid">25313960</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X-B</given-names></name><name><surname>Frerking</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Delivery of AMPA receptors to perisynaptic sites precedes the full expression of long-term potentiation</article-title><source>PNAS</source><volume>105</volume><fpage>11388</fpage><lpage>11393</lpage><pub-id pub-id-type="doi">10.1073/pnas.0802978105</pub-id><pub-id pub-id-type="pmid">18682558</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yudowski</surname><given-names>GA</given-names></name><name><surname>Puthenveedu</surname><given-names>MA</given-names></name><name><surname>Leonoudakis</surname><given-names>D</given-names></name><name><surname>Panicker</surname><given-names>S</given-names></name><name><surname>Thorn</surname><given-names>KS</given-names></name><name><surname>Beattie</surname><given-names>EC</given-names></name><name><surname>von Zastrow</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>11112</fpage><lpage>11121</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2465-07.2007</pub-id><pub-id pub-id-type="pmid">17928453</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Caenorhabditis elegans</italic>)</td><td align="left" valign="bottom">AVA GLR-1::GFP<break/>(transgenic strain)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">FJH 18</td><td align="left" valign="bottom">Genotype: <italic>akIs141</italic> II; <italic>glr-1(ky176</italic>) III<break/>akIs141 contents:<break/><italic>Prig-3::GLR-1::GFP</italic> (integrated)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA SEP::GLR-1<break/>(transgenic strain)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">FJH 314</td><td align="left" valign="bottom">Genotype: <italic>akIs172</italic>; <italic>glr-1(ky176</italic>) III<break/>akIs172 contents:<break/><italic>Prig-3::SEP::GLR-1 + Peat-4::ChR2::mCherry (integrated</italic>)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA ChRimson and mito-roGFP<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 402</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts) X; lite-1(ok530</italic>) X; <italic>csfEx160</italic><break/>csfEx160 contents: pRD30 + pRD15 + pJM23 + pCT61</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA ChRimson and cyto-GCaMP<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 412</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts) X; lite-1(ok530</italic>) X; <italic>csfEx167</italic><break/>csfEx167 contents: pRD30 + pAS1 + pJM23</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA mitoKR and mito-roGFP<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 416</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts) X; lite-1(ok530</italic>) X; <italic>csfEx168</italic><break/>csfEx168 contents: pRD36 + pRD15 + pJM23</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA GLR-1::GFP and mitoKR (transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 555</td><td align="left" valign="bottom">Genotype: <italic>akIs141</italic> II<italic>; glr-1(ky176</italic>) III; <italic>csfEx188</italic><break/>csfEx188 contents: pRD36 + pJM23 + pCT61</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA GLR-1::GFP in <italic>mcu-1(lf</italic>) (transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 576</td><td align="left" valign="bottom">Genotype: <italic>akIs141</italic> II<italic>; glr-1(ky176</italic>) III; <italic>mcu-1(ju1154</italic>) IV</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA SEP::GLR-1 with mitoKR<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 582</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts</italic>) X; <italic>glr-1(ky176</italic>) III <italic>csfEx210</italic><break/>csfEx210 contents: pRD36 + pDM1442 + pJM23</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA SEP::GLR-1<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 635</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts</italic>) X; <italic>glr-1(ky176</italic>) III <italic>csfEx234</italic><break/>csfEx234 contents: pDM1442 + pJM23 + pCT61</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA SEP::GLR-1 in <italic>mcu-1(lf</italic>)<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 638</td><td align="left" valign="bottom">Genotype: <italic>akIs172</italic> II<italic>; glr-1(ky176</italic>) III; <italic>mcu-1(ju1154</italic>) IV</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA ChRimson and GCaMP in <italic>mcu-1(lf</italic>)<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 641</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts</italic>) X; <italic>mcu-1(ju1154</italic>) IV; <italic>csfEx261</italic><break/>csfEx261 contents: pRD30 + pAS1 + pJM23 + pCT61</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA ChRimson and mito-GCaMP<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 644</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts), lite-1(ok530</italic>) X; <italic>csfEx264</italic><break/>csfEx264 contents: pKK01 + pRD30 + pJM23 + pCT61</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA ChRimson and mito-GCaMP in <italic>mcu-1(lf</italic>)<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 647</td><td align="left" valign="bottom">Genotype: <italic>lin-15(n765ts), lite-1(ok530</italic>) X<italic>; mcu-1(ju1154</italic>) IV; <italic>csfEx264</italic><break/>csfEx264 contents:<break/><italic>see above</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA SEP::GLR-1 and mito-TdTom.<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 690</td><td align="left" valign="bottom">Genotype: <italic>glr-1(ky176) III; csfEx268</italic><break/>csfEx268 contents: pKK07 + pDM1442 + pCT61</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">AVA ChRimson and mito-roGFP<break/>(transgenic strain)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FJH 706</td><td align="left" valign="bottom">Genotype: <italic>lite-1(ok530</italic>) X<italic>; mcu-1(ju1154</italic>) IV<italic>; csfEx160</italic><break/>csfEx160 contents: pRD30 + pRD15 + pJM23 + pCT61</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA mito-roGFP (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15</td><td align="left" valign="bottom"><italic>Pflp-18::TOMM-20::roGFP::let-858</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA ChRimson TdTomato (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD30</td><td align="left" valign="bottom"><italic>Pflp-18::ChRimson::tdTomato::let-858</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA mitoKR (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD36</td><td align="left" valign="bottom"><italic>Pflp-18::TOMM-20::KillerRed::let-858</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA mito-GCaMP (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pKK01</td><td align="left" valign="bottom"><italic>Pflp-18::mito4x-GCaMP6f::let-858</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA mito-TdTomato<break/>(plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pKK07</td><td align="left" valign="bottom"><italic>Pflp-18::TOMM-20::tdTomato::let-858</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA ChRimson mCherry (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pED01</td><td align="left" valign="bottom"><italic>Pflp18::ChRimson::mCherry</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA cytoplasmic GCaMP (plasmid)</td><td align="left" valign="bottom">Stetak Lab, University of Zurich</td><td align="left" valign="bottom">pAS1</td><td align="left" valign="bottom"><italic>Prig-3::GCaMP6f::unc-54</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA SEP-tagged GLR-1 (plasmid)</td><td align="left" valign="bottom">Maricq Lab, University of Utah</td><td align="left" valign="bottom">pDM1442</td><td align="left" valign="bottom"><italic>Prig-3::SEP::GLR-1::unc-54</italic> 5’UTR</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom"><italic>Lin-15</italic> rescue (plasmid)</td><td align="left" valign="bottom">Maricq Lab, University of Utah</td><td align="left" valign="bottom">pJM23</td><td align="left" valign="bottom"><italic>Plin-15::lin-15<sup>+</sup></italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Filler DNA<break/>(plasmid)</td><td align="left" valign="bottom">Stratagene</td><td align="left" valign="bottom">pBSKS</td><td align="left" valign="bottom">For plasmid recombination into extrachromosomal array</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Co-injection marker (plasmid)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">pCT61</td><td align="left" valign="bottom"><italic>Pegl-20::nls::DsRed</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA mCherry tagged SOL-1 (plasmid)</td><td align="left" valign="bottom">Maricq Lab, University.of Utah</td><td align="left" valign="bottom">pWR38</td><td align="left" valign="bottom"><italic>Prig-3::sol-2::mCherry</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA Gateway vector (plasmid)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">pCT22</td><td align="left" valign="bottom"><italic>Gateway pENTR [4-1] Pflp-18</italic> promoter</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">ChRimson Gateway vector (plasmid)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">pFH13</td><td align="left" valign="bottom"><italic>Gateway pENTR12 ChRimson no STOP</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">TdTomato Gateway vector (plasmid)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">pGH162</td><td align="left" valign="bottom"><italic>Gateway [2-3] tdTomato_let858UTR</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Destination Gateway vector (plasmid)</td><td align="left" valign="bottom">Jorgensen Lab, University of Utah</td><td align="left" valign="bottom">pCFJ150</td><td align="left" valign="bottom"><italic>pDEST/expression vector</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">3’ UTR Gateway vector (plasmid)</td><td align="left" valign="bottom">Hoerndli Lab, CSU</td><td align="left" valign="bottom">pFH21</td><td align="left" valign="bottom"><italic>Gateway pENTR</italic> [2-3] <italic>3’UTR (let-858</italic>)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Mito-roGFP Gateway vector (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD02</td><td align="left" valign="bottom"><italic>Gateway pENTR [2-1] TOMM-20 roGFP</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">AVA cytoplasmic KillerRed (plasmid)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD22</td><td align="left" valign="bottom"><italic>Pflp-18::KillerRed::let858</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Mito-GCaMP Source (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Addgene plasmid<break/>no. 127870</td><td align="left" valign="bottom"><italic>CMV-Mito4x-GCaMP6f</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Mito-roGFP Source (plasmid)</td><td align="left" valign="bottom">De Henau Lab, University Medical Center</td><td align="left" valign="bottom">pSHD1</td><td align="left" valign="bottom"><italic>Pfbf1::TOMM20::roGFP2Tsa2::3’UTRtbb2</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pRD15</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pSDH1_F</td><td align="left" valign="bottom"><italic>ggggacaagtttgtacaaaaaagcaggctGACatgagctccaccggtg</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pRD15</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pSDH1_R</td><td align="left" valign="bottom"><italic>ggggaccactttgtacaagaaagctgggtgcttgaaaggatcttgcattt</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pRD36</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15_F</td><td align="left" valign="bottom"><named-content content-type="sequence">CTTGTACAAAGTGGTTGGATGATCG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pRD36</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15_R</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>TGCTCCAGCCTGGGCACG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pRD36</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD22_F</td><td align="left" valign="bottom"><italic><named-content content-type="sequence">GCCCAGGCTGGAGCATCCGAGGG</named-content> <named-content content-type="sequence">AGGCCCAGCC</named-content></italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pRD36</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD22_R</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>ACCACTTTGTACAAGTTAATCCTCGTCGGATCCGATGG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15_F2</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>CTTGTACAAAGTGGTTGGATGA</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15_R2</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>GTCATGTCTAACCCTGAAATT</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">AG127870_F</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>AGGGTTAGACATGACATGAGCGTGCTGACACCTCTG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">AG127870_R</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>ACCACTTTGTACAAGCTGATCAGCGGGTTTAAACGGG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK07</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15_F3</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>CTTGTACAAAGTGGTTGGATGATCG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK07</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD15_R3</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>TGCTCCAGCCTGGGCACG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK07</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pGH162_F</td><td align="left" valign="bottom"><italic><named-content content-type="sequence">GCCCAGGCTGGAGCATGGTGAGC</named-content> <named-content content-type="sequence">AAGGGCGAGG</named-content></italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pKK07</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pGH162_R</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>ACCACTTTGTACAAGTTACTTGTACAGCTCGTCCATGCC</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pED01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD30_F</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>GGATGATCGACGCCAACGT</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pED01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pRD30_R</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>CCACTTTGTACAAGAAAGCTGGGT</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pED01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pWR80_F</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>TCTTGTACAAAGTGGTGGTCTCAAAGGGTGAAGAAG</italic></named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers for cloning pED01</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">pWR80_R</td><td align="left" valign="bottom"><named-content content-type="sequence"><italic>TGGCGTCGATCATCCCACCATATTCCTTATACAATTCATC</italic></named-content></td></tr></tbody></table></table-wrap></app><app id="appendix-2"><title>Appendix 2</title><sec sec-type="appendix" id="s8"><title>FRAP assays of tagged GLR-1</title><p><xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1A</xref> illustrates the differential effect of photobleaching (PB) on SEP-tagged GLR-1 based on subcellular location. Recovery of SEP fluorescence after PB is indicative of the balance between GLR-1 recruitment (i.e., via exocytosis from transport vesicles or synaptic endosomes) and recycling (i.e., via receptor endocytosis). As illustrated in <xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1B</xref>, GLR-1::GFP allows for visualization of all GLR-1 molecules, including those positioned at the synaptic membrane or in endosomes. Following PB of GFP, the fluorescence recovery indicates that new GLR-1 has been transported and delivered to the synaptic membrane or endosome within the region of interest.</p><fig id="app2fig1" position="float"><label>Appendix 2—figure 1.</label><caption><title>FRAP assays of tagged GLR-1.</title><p>(<bold>A</bold>) Illustration of subcellular SEP::GLR-1 localization. Following photobleaching (PB) of fluorescing SEP (attached to GLR-1 positioned at the synaptic membrane), recovery of SEP fluorescence is indicative of the rate of GLR-1 exocytosis from transport vesicles or synaptic endosomes and receptor endocytosis. (<bold>B</bold>) Illustration depicting the localization of GLR-1::GFP to the synaptic membrane or in endosomes. Following PB of GFP, the fluorescence recovery indicates that new GLR-1 has been transported and delivered to the synaptic membrane or endosome within the region of interest.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92376-app2-fig1-v2.tif"/></fig></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92376.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dickman</surname><given-names>Dion K</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>University of Southern California</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2023.08.07.552290" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2023.08.07.552290"/></front-stub><body><p>This study examines an interplay between synaptic mitochondria and glutamate receptor exocytosis in <italic>C. elegans</italic>. Collectively, the solid results support the idea that mitochondrial function influences receptor dynamics at postsynaptic sites. This is important because tight control of synaptic function likely integrates several mitochondrial functions: energy production, calcium buffering, and (here) reactive oxygen species signaling.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92376.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dickman</surname><given-names>Dion K</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>University of Southern California</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Frank</surname><given-names>C Andrew</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/036jqmy94</institution-id><institution>University of Iowa</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2023.08.07.552290">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2023.08.07.552290v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Activity-dependent Mitochondrial ROS Signaling Regulates Recruitment of Glutamate Receptors to Synapses&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Lu Chen as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The following key revisions are expected in a revised manuscript:</p><p>1) There appears to be a mismatch between the text and the data presented in Figure 2.</p><p>2) The Framing of the study: There does not seem to be a coherent mechanistic connection from calcium to MCU to mitochondria to ROS, though the text in the manuscript implies this. The authors should revise both the results and the Discussion sections to clarify their findings.</p><p>3) Several key experiments are suggested to strengthen and expand this study. This includes depleting ROS in the system to confirm the proposed model. Also, given that the KillerRed generation of ROS resulted in a reduction in all parameters measured, there is a concern that a large amount of ROS generated might lead to toxicity. Perhaps using another method to manipulate ROS would be helpful. Examining another cellular process that is not altered would help validate that the KillerRed is not toxic, such as looking at the transport of at least one other protein.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Text revisions would be sufficient for almost all of the issues and questions delineated above. Figure 2 should be clarified, so the data match the text.</p><p>Optionally, the authors could round out experiments (more mechanical stimulation, other modes of enhancing ROS, scavenging ROS to see if there is a phenotype reversal, etc.). Those kinds of tests could potentially bolster the story (though they would not change the core conclusions).</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. The authors found that optical activation of Chrimson expressed in AVA leads to increased calcium uptake into mitochondria based on mitoGCaMP signal and this increase is dependent on the mitochondrial calcium transporter mcu-1 (Figure 1). The authors found that GCaMP signal increases to varying amounts in different regions of the dendrite and after each stimulus suggesting that mitochondria are diverse. The differences in GCaMP signal for the different clusters of mitochondria could be due to changes in the numbers of mitochondria in each cluster (if they redistribute after each stimulus) or perhaps due to the proximity of the mitochondria to calcium channels. The authors should consider analyzing the distribution of mitochondria in AVA after repeated stimuli and the relationship of the mitochondria to VGCCs? One might expect mitochondrial clusters closest to VGCCs to have higher increases in mitoGCaMP signal after stimulation.</p><p>2. The authors state that (line 86) &quot;most dendritic mitochondria were located in close proximity to clusters of surface localized GLR-1….&quot; If ROS have a range of action of 1um, it would be informative to know what percentage of mitochondria are within 1um of GLR-1-GFP.</p><p>3. In Figure 2, the authors show that blocking calcium uptake into mitochondria leads to increased exocytosis of GLR-1 (as measured by FRAP of SEP-GLR-1) suggesting that increased calcium in mitochondria is important for regulating GLR-1. However, it remains possible that the inability of mitochondria to take up calcium results in a local increase in cytoplasmic calcium, which then promotes exocytosis of GLR-1. Although the authors show that cytoplasmic GCaMP6f fluorescence does not change under these conditions, GCaMP6f may not be sensitive enough to report local changes in cytoplasmic calcium. Also, although the peak GCaMP6f signal under the various conditions in Figure S2F are similar, the shapes of the curves appear to differ with mcu-1(lf) and Ru360 having prolonged tails indicative of higher residual cytoplasmic calcium. Is it possible to test whether sequestering cytoplasmic calcium near mitochondria affects FRAP of SEP-GLR-1 in mcu-1 genetic mutants?</p><p>4. For Figure 2D and 2E, the authors conclude that (line 165): &quot;… the rate of GLR-1-GFP FRAP in mcu-1(lf) was comparable to controls whereas the rate of FRAP in Ru360 treated animals was slightly increased.&quot; However, Figure 2E shows a significant decrease in FRAP of GLR-1-GFP in mcu-1 genetic mutants.</p><p>5. The GLR-1-GFP clusters shown in the &quot;Before&quot; images in mcu-1(lf) appear larger and more defined than in the Control image (Figure 2D). Does mcu-1(lf) affect synapse size or number?</p><p>6. Given that calcium uptake into mitochondria can stimulate ATP production, is it possible that less ATP production in mcu-1(lf) results in decreased GLR-1 transport events? Can the authors measure the transport of another unrelated cargo in mcu-1(lf) to test if motor-dependent transport is generally altered?</p><p>7. The authors should add to the discussion a few sentences about known mechanisms of how calcium uptake into mitochondria leads to ROS production.</p><p>8. Figure 4 shows that photoactivation of mitoKR leads to a reduction in all parameters tested (decreased FRAP of SEP-GLR-1, decreased FRAP of GLR-1-GFP and decreased FRAP of GLR-1 transport) raising concern that the levels of ROS generated by mitoKR may be non-specifically toxic to cellular processes. Are the levels of ROS generated after photoactivation of mitoKR comparable to the ROS levels observed after neuronal stimulation (as shown in Figure 3)?</p><p>9. The GLR-1-GFP clusters in the &quot;Before&quot; images in Figure 4D look altered in mitoKR versus control. Is GLR-1-GFP intensity and distribution altered in <italic>C. elegans</italic> expressing mitoKR?</p><p>10. The mcu-1(lf) genetic mutant has a stronger effect on FRAP of SEP-GLR-1 than the drug Ru360. The experiment shown in Figure 5C would be more compelling if the mitoKR activation was performed in mcu-1(lf).</p><p>11. The model that increased uptake of calcium into mitochondria via mcu-1 leads to increased mitochondrial production of ROS, and that the increase in ROS is responsible for regulating GLR-1 would be stronger if a loss of function ROS experiment could be performed. The concern is that blocking calcium entry into mitochondria in mcu-1(lf) could affect other mitochondrial functions in addition to loss of ROS that could be responsible for the effects of mcu-1(lf) on GLR-1 trafficking. If ChRimson activation leads to decreased FRAP of SEP-GLR-1, then one could test if depleting ROS with a scavenger or preventing mitochondrial ROS generation blocked the effects of neuronal activation on GLR-1 exocytosis. Alternatively, does depletion of ROS lead to increased FRAP of SEP as observed in mcu-1(lf) genetic mutants (Figure 2)? If the model is correct, depletion of ROS would be predicted to mimic the effects of mcu-1(lf) on GLR-1 trafficking.</p><p><italic>Reviewer #4 (Recommendations for the authors):</italic></p><p>The term &quot;FRAP rate&quot; is not clearly defined in the manuscript, leaving the exact comparisons ambiguous. Evaluating metrics like time constants, diffusion coefficients, and mobile fractions derived from the FRAP recovery curve could offer deeper insights into the endosomal trafficking of GLR-GFP.</p><p>The use of GLR-SEP is not validated within the manuscript. It would be beneficial if the authors included videos of the FRAP experiments utilizing GLR-SEP. Given that GLR-SEP solely labels AMPA receptors on the cell surface, these videos should primarily display exocytosis events, excluding endosomal trafficking. Quantifying the number or frequency of these exocytosis events would provide a more direct assessment of AMPA receptor exocytosis. The &quot;FRAP&quot; recovery encompasses exocytosis, endocytosis, and lateral diffusion, which might not accurately capture alterations in exocytosis alone.</p><p>The authors observed an increase in raw fluorescence recovery for GLR-SEP in the MCU-1 mutant compared to the wild-type (Figure 2C), yet found that the percentage of recovery remained consistent in the mutant condition (Figure S2C). They inferred an elevation in exocytosis in the MCU-1 mutant based on these findings. However, there are concerns with this conclusion. Firstly, the FRAP experiments do not offer a direct assessment of exocytosis. Secondly, if the total expression level of GLR-SEP is augmented in the MCU-1 mutant, the raw fluorescence recovery could inherently be faster than that of the wild-type. The inclusion of appropriate controls is essential to validate these outcomes more robustly.</p><p>Figure 5B shows an enhanced % FRAP recovery for GLR-SEP in the control+PA Ru360 compared to the untreated group. However, Figure S2C doesn't indicate any difference between the Ru360 and untreated groups. Could the authors elucidate the inconsistency observed between these datasets?</p><p>There are discrepancies observed in the data presented. In Figure 2E and 2G, both FRAP recovery and trafficking events of GLR-GFP appear reduced in the MCU-1 mutant. Conversely, Figure 4E and 4H show a reduction in FRAP recovery and trafficking in the mitoKR condition. Given that ROS is diminished in the MCU-1 mutant but elevated during mitoKR global activation, can the authors elucidate and discuss these findings in greater detail? The current working model lacks clarity.</p><p>A clearer presentation might involve splitting the working model in Figure 6 into two distinct parts. One should depict the effect of ROS on AMPA receptor dendritic trafficking, while the other illustrates its influence on AMPA receptor surface expression/excocytosis. Given the potential differential impacts of mitochondrial calcium and ROS on these mechanisms, delineating the models for each process separately would enhance comprehension of the findings.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92376.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The following key revisions are expected in a revised manuscript:</p><p>1) There appears to be a mismatch between the text and the data presented in Figure 2.</p></disp-quote><p>We thank the reviewers and editors for their detailed review of our manuscript. This unintentional mismatch has been fixed with changes to the manuscript text.</p><disp-quote content-type="editor-comment"><p>2) The Framing of the study: There does not seem to be a coherent mechanistic connection from calcium to MCU to mitochondria to ROS, though the text in the manuscript implies this. The authors should revise both the results and the Discussion sections to clarify their findings.</p></disp-quote><p>We agree that we were not able to elucidate all relevant players involved in the proposed mechanism. So, it is indeed more appropriate to explicitly state what parts of the proposed mechanism are supported by the data presented and what mechanistic steps are speculative based on what is known in the field of mitochondrial calcium (Ca<sup>2+</sup>) handling and redox signaling. We have made many changes to the manuscript text and the illustration of our proposed model to be more careful in making this distinction and to not overstate the implications of our findings.</p><disp-quote content-type="editor-comment"><p>3) Several key experiments are suggested to strengthen and expand this study. This includes depleting ROS in the system to confirm the proposed model. Also, given that the KillerRed generation of ROS resulted in a reduction in all parameters measured, there is a concern that a large amount of ROS generated might lead to toxicity. Perhaps using another method to manipulate ROS would be helpful. Examining another cellular process that is not altered would help validate that the KillerRed is not toxic, such as looking at the transport of at least one other protein.</p></disp-quote><p>These are all important experiments and many of which we have already conducted in one way or another. First, we have published a short report on the effects of ROS scavenging on GLR-1 transport (PMID: 35622512). In brief, we found that like the effect of increased ROS levels, genetic and strong pharmacological ROS scavenging also caused a decrease in GLR-1 transport. One of the major caveats with our previous experiments, and others that would address the point made by the reviewers, is the lack of sensitivity of current in vivo ROS sensors such as roGFP and HyPer, which do not allow establishing “low ROS” conditions within physiological range. In addition to limited sensitivity of in vivo ROS sensors, current genetic and pharmacological ROS scavenging approaches, lack cell specificity or temporal control needed for these experiments.</p><p>Second, the concern about KillerRed toxicity is valid especially since it was designed to generate relatively high levels of ROS. We worked for a long time to determine appropriate expression levels and activation protocols for KillerRed. The optical activation protocols for KillerRed used in this study were optimized to results in ROS elevations that are similar to what is elicited by native neuronal activity (e.g., resulting from mechanosensation). The side-by-side comparison of mito-roGFP measurements resulting from mechanosensory stimulation, and local or global mitoKillerRed activation demonstrates that KillerRed activation causes ROS elevations that are comparable to those that arise normally following repetitive neuronal activation. We have rearranged the main text, figures, and figure supplements to allow for these important validations to be discussed and shown as a main figure (Figure 4).</p><p>Lastly, we agree that assessing if mitoROS alters the transport of other proteins is important and would not only further support our KillerRed activation protocol, but also provide insight into the specificity of mitoROS signaling on GLR-1 transport. However, this requires the creation and validation of <italic>C. elegans</italic> strains with cell-specific expression of fluorescently labeled proteins (e.g., NMDA receptors such as NMR-1/2) that we currently do not have. We plan to develop these strains and carry out follow-up experiments with KillerRed and mitoROS that would test our reagents, conditions, and model. These would be published as follow-up or stand-alone studies depending on their content and significance. In the meantime, however, we have analyzed transport velocities of GLR-1, which to some extent reflect availability of ATP and cytoskeletal integrity in <italic>mcu-1</italic> mutants and mitoKR conditions (revised Figure 2- supplement 1C, Figure 5 supplement 1 A-B). These analyses show that transport velocities are unchanged in any of the conditions above suggesting no toxic effects of these conditions on kinesin-mediated transport.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Text revisions would be sufficient for almost all of the issues and questions delineated above. Figure 2 should be clarified, so the data match the text.</p><p>Optionally, the authors could round out experiments (more mechanical stimulation, other modes of enhancing ROS, scavenging ROS to see if there is a phenotype reversal, etc.). Those kinds of tests could potentially bolster the story (though they would not change the core conclusions).</p></disp-quote><p>We thank the reviewer for suggesting text changes to clarify our results and we hope we have addressed their concerns (see detailed responses above).</p><p>We agree that using mechanical stimulation or other methods for increasing mitoROS to further support this mechanism would be ideal. The current available reagent and approaches, lack sensitivity, cell specificity, subcellular localization control or temporal control or a combination of these. We are currently developing new reagents and approaches that will test our model and follow up on the results we present here.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. The authors found that optical activation of Chrimson expressed in AVA leads to increased calcium uptake into mitochondria based on mitoGCaMP signal and this increase is dependent on the mitochondrial calcium transporter mcu-1 (Figure 1). The authors found that GCaMP signal increases to varying amounts in different regions of the dendrite and after each stimulus suggesting that mitochondria are diverse. The differences in GCaMP signal for the different clusters of mitochondria could be due to changes in the numbers of mitochondria in each cluster (if they redistribute after each stimulus) or perhaps due to the proximity of the mitochondria to calcium channels. The authors should consider analyzing the distribution of mitochondria in AVA after repeated stimuli and the relationship of the mitochondria to VGCCs? One might expect mitochondrial clusters closest to VGCCs to have higher increases in mitoGCaMP signal after stimulation.</p></disp-quote><p>We agree that investigating mitochondrial positioning and how it would shape mitochondrial function and calcium propagation would be interesting and insightful work. However, this warrants a follow-up study of its own. Indeed, we are currently in the process of deepening our analysis of mitochondrial distribution, morphology and Ca<sup>2+</sup> propagation in vivo using some of the tools developed for this study.</p><disp-quote content-type="editor-comment"><p>2. The authors state that (line 86) &quot;most dendritic mitochondria were located in close proximity to clusters of surface localized GLR-1….&quot; If ROS have a range of action of 1um, it would be informative to know what percentage of mitochondria are within 1um of GLR-1-GFP.</p></disp-quote><p>We have done this analysis and included in the results (at line 163-164) that around 61% of mitochondria are located within 1 µm of a SEP::GLR-1 cluster/puncta. However, this is only an estimation because the two AVA neurites run directly adjacent to one another, so we are unable to precisely distinguish whether GLR-1 clusters and mitochondria reside within the same AVA neurite. Additionally, this estimation should not be construed to mean that about 61% mitochondria are located near glutamatergic synapses because GLR-1 clusters exist in these neurites without a presynaptic terminal nearby (PMID: 12123612).</p><disp-quote content-type="editor-comment"><p>3. In Figure 2, the authors show that blocking calcium uptake into mitochondria leads to increased exocytosis of GLR-1 (as measured by FRAP of SEP-GLR-1) suggesting that increased calcium in mitochondria is important for regulating GLR-1. However, it remains possible that the inability of mitochondria to take up calcium results in a local increase in cytoplasmic calcium, which then promotes exocytosis of GLR-1. Although the authors show that cytoplasmic GCaMP6f fluorescence does not change under these conditions, GCaMP6f may not be sensitive enough to report local changes in cytoplasmic calcium. Also, although the peak GCaMP6f signal under the various conditions in Figure S2F are similar, the shapes of the curves appear to differ with mcu-1(lf) and Ru360 having prolonged tails indicative of higher residual cytoplasmic calcium. Is it possible to test whether sequestering cytoplasmic calcium near mitochondria affects FRAP of SEP-GLR-1 in mcu-1 genetic mutants?</p></disp-quote><p>The sensitivity of GCaMP6f could surely occlude subtle changes in cytoplasmic calcium when <italic>mcu-1</italic> is absent or blocked. We also noticed that some GCaMP peaks had a prolonged shoulder suggesting delayed calcium buffering, but this feature was not consistently observed in our dataset and was not robust enough to be detected by our ‘Total Activity’ measurement (revised Figure 2I-J) which would detect changes in the duration of ca<sup>2+</sup> events. We could employ a more sensitive calcium indicator (i.e., jGCaMP8), and are currently developing transgenic strains and imaging approaches to follow up on our result in this study. We are unaware of current genetically encoded reagents that would help sequester calcium locally at mitochondria with subcellular and temporal control.</p><disp-quote content-type="editor-comment"><p>4. For Figure 2D and 2E, the authors conclude that (line 165): &quot;… the rate of GLR-1-GFP FRAP in mcu-1(lf) was comparable to controls whereas the rate of FRAP in Ru360 treated animals was slightly increased.&quot; However, Figure 2E shows a significant decrease in FRAP of GLR-1-GFP in mcu-1 genetic mutants.</p></disp-quote><p>The confusion is due to an incorrect statement in the results text. We have corrected this error and appreciate the reviewer for bringing it to our attention.</p><disp-quote content-type="editor-comment"><p>5. The GLR-1-GFP clusters shown in the &quot;Before&quot; images in mcu-1(lf) appear larger and more defined than in the Control image (Figure 2D). Does mcu-1(lf) affect synapse size or number?</p></disp-quote><p>We observed a slight but not significant increase in the size and intensity GLR-1::GFP puncta in <italic>mcu-(lf)</italic> mutants (data not shown), but puncta number remained comparable to controls.</p><disp-quote content-type="editor-comment"><p>6. Given that calcium uptake into mitochondria can stimulate ATP production, is it possible that less ATP production in mcu-1(lf) results in decreased GLR-1 transport events? Can the authors measure the transport of another unrelated cargo in mcu-1(lf) to test if motor-dependent transport is generally altered?</p></disp-quote><p>This is possible and although we could do an additional experiment to analyze transport of another unrelated cargo, we have added supplemental transport velocity data (revised Figure 2 -supplement 1C) that suggests ATP levels are comparable between <italic>mcu-1(lf)</italic> and controls. The processivity of molecular motors requires a consistent supply of ATP. Thus, if ATP was decreased in <italic>mcu-1(lf),</italic> then transport would occur at a slower rate. Instead, we found that transport velocities were nearly identical between <italic>mcu-1(lf)</italic> and controls.</p><disp-quote content-type="editor-comment"><p>7. The authors should add to the discussion a few sentences about known mechanisms of how calcium uptake into mitochondria leads to ROS production.</p></disp-quote><p>We have added discussion and some additional citations to reviews on this topic.</p><disp-quote content-type="editor-comment"><p>8. Figure 4 shows that photoactivation of mitoKR leads to a reduction in all parameters tested (decreased FRAP of SEP-GLR-1, decreased FRAP of GLR-1-GFP and decreased FRAP of GLR-1 transport) raising concern that the levels of ROS generated by mitoKR may be non-specifically toxic to cellular processes. Are the levels of ROS generated after photoactivation of mitoKR comparable to the ROS levels observed after neuronal stimulation (as shown in Figure 3)?</p></disp-quote><p>Yes, our KillerRed photoactivation protocol increases ROS at mitochondria to a similar level as neuronal activation. More specifically, 10 minutes of mechano-stimulation (revised Figure 4A-B) and 5 minutes of repetitive optical stimulation (revised Figure 3B-C; see more detail in response to Reviewer 2 – Recommendations for the authors) led to an approximate doubling of the roGFP F<sub>ratio</sub> as did both of our local photoactivation protocol for mitoKR activation (Figure 4C-E). Our 10-minute global photoactivation of mitoKR caused only a modest increase in the roGFP F<sub>ratio</sub> (~30% increase) (revised Figure 4G-H). This data is now shown in a new Figure 4 to explicitly show that our mitoKR activation protocol increases mitoROS to a similar or even lesser extent than what is elicited by neuronal activity.</p><disp-quote content-type="editor-comment"><p>9. The GLR-1-GFP clusters in the &quot;Before&quot; images in Figure 4D look altered in mitoKR versus control. Is GLR-1-GFP intensity and distribution altered in <italic>C. elegans</italic> expressing mitoKR?</p></disp-quote><p>We did not detect any changes in the intensity or density of GLR-1::GFP puncta with mitoKR (data not shown) or increased genetically (PMID: 32847966). This difference is probably due to the natural heterogeneity we see in GLR-1 cluster localization and density which can be also seen in Figure 2 and in our previously published work (PMIDs: 32847966, 25843407).</p><disp-quote content-type="editor-comment"><p>10. The mcu-1(lf) genetic mutant has a stronger effect on FRAP of SEP-GLR-1 than the drug Ru360. The experiment shown in Figure 5C would be more compelling if the mitoKR activation was performed in mcu-1(lf).</p></disp-quote><p>We understand why the reviewer would suggest combining <italic>mcu-1(lf)</italic> and mitoKR based on the severity of the <italic>mcu-1(lf)</italic> phenotype. However, we reasoned it would make more sense to combine acute treatments (Ru360 and mitoKR activation) without possible developmental changes generally associated with genetic <italic>loss-of-functions</italic>. More specifically, <italic>mcu-1(lf)</italic> led to increased synaptic GLR-1 puncta (revised Figure2-supplement 1A) that was more severe than acute Ru360 treatment, so we worried that these changes were at least partially developmental and unlikely to be compensated by an acute photoactivation of mitoKR.</p><disp-quote content-type="editor-comment"><p>11. The model that increased uptake of calcium into mitochondria via mcu-1 leads to increased mitochondrial production of ROS, and that the increase in ROS is responsible for regulating GLR-1 would be stronger if a loss of function ROS experiment could be performed. The concern is that blocking calcium entry into mitochondria in mcu-1(lf) could affect other mitochondrial functions in addition to loss of ROS that could be responsible for the effects of mcu-1(lf) on GLR-1 trafficking. If ChRimson activation leads to decreased FRAP of SEP-GLR-1, then one could test if depleting ROS with a scavenger or preventing mitochondrial ROS generation blocked the effects of neuronal activation on GLR-1 exocytosis. Alternatively, does depletion of ROS lead to increased FRAP of SEP as observed in mcu-1(lf) genetic mutants (Figure 2)? If the model is correct, depletion of ROS would be predicted to mimic the effects of mcu-1(lf) on GLR-1 trafficking.</p></disp-quote><p>One of the main other “mitochondrial functions” that could be impacted by loss of <italic>mcu-1(lf)</italic> would be ATP production. We have added GLR-1 transport velocity data showing no change in transport velocity indicating that ATP levels are comparable between <italic>mcu-1(lf)</italic> and controls (revised Figure 2-supplement 1C). We agree that the concern of ROS-independent effects in <italic>mcu-1(lf)</italic> would be reduced by data showing decreased ROS levels increase synaptic delivery and exocytosis in a similar fashion to <italic>mcu-1(lf).</italic> We have not done these experiments but is something we could do. However, we would not be able to validate our methods for reducing ROS because the ROS sensitivity range of mito-roGFP is too high to detect decreases in basal mitoROS (meaning below 10 nM). We have shown that genetic and pharmacological means of decreasing ROS decreased GLR-1 transport (opposite from what was expected) but via a mechanism independent of cytoplasmic ca<sup>2+</sup> signaling (PMID: 35622512). Addressing this will depend on the development of more sensitive ROS indicators necessary to test the efficacy of antioxidant treatments in vivo.</p><disp-quote content-type="editor-comment"><p>Reviewer #4 (Recommendations for the authors):</p><p>The term &quot;FRAP rate&quot; is not clearly defined in the manuscript, leaving the exact comparisons ambiguous. Evaluating metrics like time constants, diffusion coefficients, and mobile fractions derived from the FRAP recovery curve could offer deeper insights into the endosomal trafficking of GLR-GFP.</p></disp-quote><p>We thank the reviewer for this insightful comment. We do agree that the term “FRAP rate” should be described in better detail. We did not obtain accurate measures of time constants, mobile fractions, and diffusion coefficients because the time required to reach a steady-state FRAP for GLR-1 (i.e., a plateau in the % FRAP recovery curve) requires long imaging durations (&gt; 45 min.) that are problematic in vivo due to hypoxia and starvation.</p><disp-quote content-type="editor-comment"><p>The use of GLR-SEP is not validated within the manuscript. It would be beneficial if the authors included videos of the FRAP experiments utilizing GLR-SEP. Given that GLR-SEP solely labels AMPA receptors on the cell surface, these videos should primarily display exocytosis events, excluding endosomal trafficking. Quantifying the number or frequency of these exocytosis events would provide a more direct assessment of AMPA receptor exocytosis. The &quot;FRAP&quot; recovery encompasses exocytosis, endocytosis, and lateral diffusion, which might not accurately capture alterations in exocytosis alone.</p></disp-quote><p>This is a very good point. Ideally, SEP tagged reagents are validated in cell culture using buffers of various pH levels. However, this is not possible in vivo in intact <italic>C. elegans.</italic> SEP::GLR-1 more than likely does not exclusively label surface receptors due to the rate of acidification of endosomes and the delay for pH quenching of SEP fluorescence (1-3 minutes; PMID: 29899033). Although infrequent, we do see SEP labeling of vesicles undergoing transport and perhaps very low ER signal. Based on short image streams (60 s) of SEP::GLR-1 following photobleaching, we are confident that the majority of our SEP::GLR-1 signal is at the synaptic surface. Specifically, we see only occasional transport (1-2 events per minute) and some faint exocytosis events that resulted in stable SEP::GLR-1 fluorescence (data not shown).</p><p>Although we agree that quantifying exocytosis events in videos would provide a better assessment of exocytosis only, this requires high imaging rates (20-50 fps) that result in a signal to noise ratio that is too low to reproducibly and consistently observe dim exocytosis events in vivo using SEP::GLR-1. Second, it is technically very difficult to locate the ideal focal plane where exocytosis happens at the membrane in vivo. SEP::GLR-1 FRAP is not a measure of only exocytosis but reflects the balance between exo- and endocytosis and is currently the only in vivo measurement of synaptic GLR-1 recruitment possible in our hands. We agree that this should more clearly written in the text and have now modified the manuscript to reflect this excellent observation from the reviewer. With the on-going development of new reagents and optical hardware, we plan to follow up with more precise experiments to assess if/how mitoROS individually affects exocytosis, diffusion, and endocytosis of GLR-1.</p><disp-quote content-type="editor-comment"><p>The authors observed an increase in raw fluorescence recovery for GLR-SEP in the MCU-1 mutant compared to the wild-type (Figure 2C), yet found that the percentage of recovery remained consistent in the mutant condition (Figure S2C). They inferred an elevation in exocytosis in the MCU-1 mutant based on these findings. However, there are concerns with this conclusion. Firstly, the FRAP experiments do not offer a direct assessment of exocytosis. Secondly, if the total expression level of GLR-SEP is augmented in the MCU-1 mutant, the raw fluorescence recovery could inherently be faster than that of the wild-type. The inclusion of appropriate controls is essential to validate these outcomes more robustly.</p></disp-quote><p>We do agree that the increase in basal GLR-1 in the <italic>mcu-1</italic> mutants makes interpreting the results of our FRAP experiments for <italic>mcu-1(lf)</italic> difficult. It is important to point out that basal GLR-1::GFP was not increased in <italic>mcu-1(lf)</italic> (data not shown) which suggests that the number of receptors at synaptic sites (either positioned in endosomal pools or at the membrane) is comparable between <italic>mcu-1(lf)</italic> and controls. When this result is considered alongside the increase in SEP::GLR-1 in <italic>mcu-1(lf)</italic>, it indicates that relatively more GLR-1 receptors are positioned at the membrane in <italic>mcu-1(lf)</italic>. We also agree with the reviewer that FRAP of GLR-1 encompasses more than exocytosis as mentioned above. We have also modified the text of the manuscript to use “synaptic recruitment” instead of exocytosis as mentioned at the end of our response to reviewer #3.</p><disp-quote content-type="editor-comment"><p>Figure 5B shows an enhanced % FRAP recovery for GLR-SEP in the control+PA Ru360 compared to the untreated group. However, Figure S2C doesn't indicate any difference between the Ru360 and untreated groups. Could the authors elucidate the inconsistency observed between these datasets?</p></disp-quote><p>For the SEP FRAP experiment for Figure 2, the background <italic>C. elegans</italic> strain (FJH 314, Appendix 1, Key Resources Table after figure legends) contained an integrated SEP::GLR-1 array allowing for more consistent expression with less inter-individual variability (which is ideal for quantifying steady-state GLR-1 levels such as in revised Figure 2-supplement 1B). Alternatively, for the SEP FRAP experiments in Figure 5 and 6 involving mitoKR, strain FJH 314 could not be used due to the co-expression of ChR2::mCherry which prevented us from validating the expression of mitoKR (which contains a red fluor) in this background. So, we had to conduct all SEP::GLR-1 FRAP experiments involving mitoKR on a different strain in which SEP::GLR-1 was expressed via an extrachromosomal array (FJH 635 and FJH 582 [containing mitoKR]). The strains used in Figure 2-supplement 1B had almost 3x higher SEP::GLR-1 compared to those used in Figure 5 (data not shown). Thus, calculating %FRAP by doing a 0-minute background subtraction followed by normalization to higher basal SEP::GLR-1 levels in the strain in Figure 2-supplement1B may have occluded the small effect of Ru360 treatment on %FRAP of SEP::GLR-1. We agree that this discrepancy should be better explained in the text, so we have mentioned that different SEP::GLR-1 expressing strains had to be used and that this may have led to inter-experimental inconsistencies. For additional transparency, we have also added the <italic>C. elegans</italic> strains used for each experiment to the main text and to all our figure legends.</p><disp-quote content-type="editor-comment"><p>There are discrepancies observed in the data presented. In Figure 2E and 2G, both FRAP recovery and trafficking events of GLR-GFP appear reduced in the MCU-1 mutant. Conversely, Figure 4E and 4H show a reduction in FRAP recovery and trafficking in the mitoKR condition. Given that ROS is diminished in the MCU-1 mutant but elevated during mitoKR global activation, can the authors elucidate and discuss these findings in greater detail? The current working model lacks clarity.</p></disp-quote><p>We thank the reviewer for pointing out the need for greater clarity in explaining our results for FRAP using GLR-1 GFP. Based on our mito-roGFP data, basal ROS levels at mitochondria in <italic>mcu-1(lf)</italic> or with Ru360 treatment are comparable to controls (see 0-minute stimulation groups in Figure 3E and 3G). Loss or inhibition of MCU-1 prevents the increase in mitoROS following neuronal stimulation which suggests that activity-dependent upregulation of mitoROS production is impacted by <italic>mcu-1(lf)</italic>/Ru360 but not basal mitoROS levels. So, based on this data, we cannot conclude that “ROS is diminished” in <italic>mcu-1(lf).</italic> Our data in revised Figure 6F suggest that the impact of <italic>mcu-1(lf)</italic> and mitoKR on GLR-1 transport involves parallel mechanisms since combining mitoKR and Ru360 doesn’t phenocopy Ru360 or mitoKR alone. We have modified our discussion of this and to our proposed model (illustrated in revised Figure 7) to more explicitly describe how our results suggest a paradoxical mechanism in which mitoROS and MCU-1 act within the same signaling pathway to regulate GLR-1 localization to the synaptic membrane (revised Figure 7B), but act in parallel signaling pathways in the neuronal soma to regulate GLR-1 export and dendritic transport (revised Figure 7A).</p><disp-quote content-type="editor-comment"><p>A clearer presentation might involve splitting the working model in Figure 6 into two distinct parts. One should depict the effect of ROS on AMPA receptor dendritic trafficking, while the other illustrates its influence on AMPA receptor surface expression/excocytosis. Given the potential differential impacts of mitochondrial calcium and ROS on these mechanisms, delineating the models for each process separately would enhance comprehension of the findings.</p></disp-quote><p>This is a great suggestion, and we agree that the illustration of our proposed model lacks mechanistic context. We have added an illustration to our model (revised figure 7A) to illustrate that our data indicates that in the cell body, MCU-1 and mitoROS act via separate signaling pathways to regulate GLR-1 transport .</p></body></sub-article></article>